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Chapter 1: General Introduction 
1.1 Cortical (mal)formation 
1.1.1 Development of the cortex 
In  the developing vertebrate central nervous system, neural  stem cells (NSCs) and progenitor 
cells generate neurons in the process of neurogenesis, which is tightly regulated in a temporal 
and spatial fashion along the different body axes (Gotz and Huttner, 2005; Taverna et al., 2014). 
Neurogenesis is followed by migration of neurons. The formation of dendrites, axons and 
synapses is the basis for the generation of neuronal connections and networks (Komuro and 
Rakic, 1998; Kriegstein and Noctor, 2004). 
The earliest progenitors of the cortex are called neuroepithelial cells (NECs). NECs 
show typical epithelial features and form the neuroepithelium, which looks layered 
(‘pseudostratified’) due to the apico‐basal movement of NEC nuclei during the cell‐cycle 
(Takahashi et al., 1995; Taverna and Huttner, 2010). NECs expand their pool by symmetric 
proliferative divisions (Taverna et al., 2014).  
At the beginning of neurogenesis, NECs divide asymmetrically to generate radial glial 
cells (RGCs) with neuroepithelial and astroglial characteristics (Gotz and Huttner, 2005; 
Kosodo et al., 2004; Malatesta et al., 2000; Miyata et al., 2004). With the generation of neurons, 
the neuroepithelium transforms into a tissue with several layers of cells. RGCs are found in the 
ventricular zone (VZ) of the cortex, the most apical cell layer that lines the ventricle (Noctor et 
al., 2002; Taverna et al., 2014). In rodents, the time window of neurogenesis in the developing 
cerebral cortex extends from embryonic day 10.5 (E10.5) to  mostly E16.5, followed by 
gliogenesis (Gotz and Huttner, 2005). First, RGCs divide asymmetrically to self‐renew and 
produce a projecting neuron in direct neurogenesis (Fig.1.1A) (Gotz and Huttner, 2005; Huttner 
and Brand, 1997).  The first neurons (born around E10.5 in the developing mouse cortex) form 
the preplate (Molyneaux et al., 2007). The preplate then splits into the marginal zone (MZ) and 
the subplate (Hevner et al., 2001; Magdaleno et al., 2002; Molyneaux et al., 2007; Wood et al., 
1992). The cortical plate (CP) forms in between the preplate and the MZ and develops into the 
multilayered neocortex later (Agirman et al., 2017; Molyneaux et al., 2007). The first waves of 
neurons populate mainly the lower cortical layers (LLs) L6 and L5 (Molyneaux et al., 2007).  
As corticogenesis proceeds, indirect neurogenesis becomes predominant as RGCs 
produce intermediate progenitor cells (IPCs) that delaminate from the VZ and invade the 
subventricular zone (SVZ) (Fig.1.1A) (Haubensak et al., 2004; Noctor et al., 2001; Noctor et 
al., 2004). In overlapping waves, IPCs undergo limited cycles of symmetric divisions to 
generate the majority of cortical neurons, which populate the upper layers (ULs) L4-L2 
(Haubensak et al., 2004; Kowalczyk et al., 2009; Letinic et al., 2002; Noctor et al., 2004; 
Tarabykin et al., 2001). The MZ develops into L1, which is populated by tangentially migrating 
Cajal-Retzius cells from outside of the neocortex, mainly from the cortical hem (Marin-Padilla, 
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1.1.2 Developmental defects leading to cortical malformation 
Any defect affecting cortical development at any stage can result in malformation of cortical 
development (MCD) (Raybaud and Widjaja, 2011; Subramanian et al., 2019). MCDs are a 
heterogeneous group of neurodevelopmental disorders. Different defects were named according 
to their morphologic feature, e.g. microcephaly for a small brain, macrocephaly for a big brain, 
lissencephaly for a smooth brain or polymicrogyria for a brain with too many small gyri 
(Raybaud and Widjaja, 2011). Combinations, e.g. microlissencephaly (brain with reduced size, 
thick cortex and defective gyration), occur as well. Microcephaly occurs non-syndromic or 
syndromic when it is part of more complex syndromes, for instance it can be associated with 
brainstem and cerebellar malformations as in pontocerebellar hypoplasia. 
Microcephaly can be evident at birth (primary microcephaly) or occur postnatally 
(secondary or postmigrational microcephaly), usually within the first years of life (Juric-Sekhar 
and Hevner, 2019; Passemard et al., 2013). Whereas primary microcephalies reflect an 
imbalance between progenitor cell production and cell death, secondary microcephaly often 
implies neurodegeneration or other cell death (Passemard et al., 2013). 
Based on the analysis of mouse models, different mechanisms were identified to be 
involved in the development of microcephaly (Fig. 1.1) (reviewed by Bizzotto and Francis, 
2015). These include defects in RGs proliferation (Fig.1.1B), premature differentiation of RGs 
into post-mitotic neurons at the expense of IPC genesis (Fig.1.1C), increased cell death 
(apoptosis) (Fig.1.1D) and defects in neuronal differentiation (Fig.1.1E). In all of these defects, 
the affected cells generate less progeny cells, finally, leading to a decreased number of neurons. 
The molecular mechanisms underlying these defects causing microcephaly are diverse. 
Environmental factors can lead to primary microcephaly, like intrauterine infections (e.g. Zika 
virus, rubella or toxoplasmosis), drugs (alcohol, cocaine or antiepileptic drugs) or other factors 
during pregnancy (e.g. malnutrition or placental insufficiency) (Devakumar et al., 2018; 
Oliveira Melo et al., 2016; Passemard et al., 2013). Additionally, genetic mutations can cause 
microcephaly and other MCDs (Barkovich et al., 2012; Juric-Sekhar and Hevner, 2019; 
Passemard et al., 2013). Several gene mutations associated with primary microcephaly are 
involved in pathways affecting the cell cycle phases of mitosis and thereby change the rate of 
neurogenesis, e.g. mutations in genes involved in cell cycle progression and checkpoint control, 
centrosome maturation and duplication, mitotic spindle formation and DNA repair (MCPH1, 
CDK5RAP2, CENPJ, NDE1 and WDR62) (Alkuraya et al., 2011; Bakircioglu et al., 2011; 
Bilguvar et al., 2010; Feng and Walsh, 2004; Thornton and Woods, 2009; Yu et al., 2010). 
Besides, also gene mutations affecting the progenitor proliferative capacity can lead to a 
reduced number of neurons and primary microcephaly (ASPM and STIL) (Desir et al., 2008; 
Kousar et al., 2010; Kumar et al., 2009; Papari et al., 2013).  
Defects in neuronal migration are often linked to lissencephaly, including mutations in 
PAFAH1B1 (formerly LS1), DCX, ARX and REELIN (Cardoso et al., 2002; Hong et al., 2000; 
Kitamura et al., 2002; Pilz et al., 1998; Pramparo et al., 2010). However, also microcephaly can 
be associated with abnormal migration as several factors that control proliferation of neural 
progenitors are essential regulators of neuronal migration (Passemard et al., 2013). For instance, 
the intermediate progenitor specific transcription factor TBR2 (EOMES) is thought to be 
involved in neuronal division and migration and its silencing leads to microcephaly (Baala et 
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al., 2007). Besides, genes involved in microtubule formation and microtubule-associated 
proteins, which are critical for cell migration, have been linked to microcephaly and various 
other MCDs (TUBA1A, TUBB2B, TUBB3, TUBG1, DYNC1H and KIF5C) (Abdollahi et al., 
2009; Bahi-Buisson et al., 2014; Di Donato et al., 2017; Kumar et al., 2010; Poirier et al., 2007; 
Poirier et al., 2010). 
A study, which investigated the genetics of microcephaly in 62 patients, identified 
transcriptional regulation and DNA damage response pathways as the most frequent affected 
pathways in both, primary and secondary, microcephaly (Boonsawat et al., 2019). Centrosome-
associated pathways were only found in primary microcephaly, corresponding to their function 
in cell division during neurogenesis. Whereas the inheritance of primary microcephaly was 
mainly recessive suggesting a complete protein absence as the most frequent cause of primary 
microcephaly, dominant de novo mutations were often observed in secondary microcephaly 
indicating that haploinsufficiency may be common for secondary microcephaly (Boonsawat et 
al., 2019).  
Figure 1.1 Mechanisms leading to primary microcephaly in mouse models. (A) In normal cortical 
development, apical radial glial progenitors (aRGs) self-renew in the ventricular zone and may generate neurons 
directly. Additionally, aRGs also produce basal intermediate progenitors (bIPs), which divide in the subventricular 
zone (SVZ) to generate more neurons. Due to their relative rarity in the mouse cortex, the basal radial glial 
progenitors (bRGs) are not included in this scheme. (B-E) Potential mechanisms leading to microcephaly, based 
on analyses of mouse models. They include defects (indicated by X marks) in the proliferation of aRGs (B), 
premature differentiation of aRGs into neurons at the expense of bIP genesis (C), increased cell death (D), and 
impairments in neuronal differentiation (E). The affected cells do not generate progeny cells (marked in light gray). 
Abbreviations: VZ, ventricular zone; SVZ, subventricular zone; CP, cortical plate; aRGs, apical radial glial 
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progenitors; bIPs, basal intermediate progenitors. Created with BioRender.com. [Adapted from (Bizzotto and 
Francis, 2015)]. 
 
1.2 ESCO2 is essential for proper sister chromatid cohesion in cell division 
1.2.1 Cell division 
The aim of cell division is to create two genetically identical daughter cells from one parent cell 
(Mitchison and Salmon, 2001). The cell grows and duplicates its genetic information during the 
interphase of the cell cycle. Afterwards, the condensed chromosomes comprise two identical 
sister chromatids each and mitosis, the step of the cell cycle in which the cell divides into two 
daughter cells, can start (Scholey et al., 2003).  
The mitotic spindle is the cytoskeletal structure including microtubules and multiple 
mitotic motors responsible for the distribution of identical copies of the replicated genome to 
the daughter cells (Mitchison and Salmon, 2001; Scholey et al., 2003; Sharp et al., 2000; 
Wittmann et al., 2001). 
The first phase of mitosis is the prophase in which the duplicated centromeres of the 
chromosomes migrate around the nucleus. Subsequently, the nuclear envelope breaks open 
enabling the microtubules to align the chromosomes to the cell equator in prometaphase 
(Kapoor and Compton, 2002).  
By metaphase, the pairs of sister chromatids are placed on the spindle equator towards 
opposite spindle poles (Kapoor and Compton, 2002). Microtubules are arranged in four sets 
linking the spindle poles to the cell cortex (astral microtubules), the chromosome arms to the 
poles (chromosomal microtubules), the poles to the kinetochores (kinetochore microtubules) 
and the two poles to each other (interpolar microtubules) (McIntosh et al., 2002; Scholey et al., 
2003; Wittmann et al., 2001).  
Next, the cohesion between sister chromatids is abrogated, so that they can be moved to 
opposite spindle poles in anaphase (Shah and Cleveland, 2000). The spindle poles move further 
apart as well in a process named pole–pole spacing (Brust-Mascher and Scholey, 2002; Sharp 
et al., 2000). At the same time, the spindle sends a signal to the cell cortex that determines the 
positioning of the contractile ring (Glotzer, 2001; Robinson and Spudich, 2000). 
In telophase, the nuclear envelope reassembles around the sets of decondensing, 
segregated sister chromatids (Guttinger et al., 2009). The contractile ring contracts and creates 
a cleavage furrow, a barrier between the daughter cells (Cao and Wang, 1990). During 
abscission, the furrow closes to finally separate the daughter cells completely (Mierzwa and 
Gerlich, 2014).  
The position of the furrow is defined by the location of the mitotic spindle during 
anaphase (Oliferenko et al., 2009; von Dassow, 2009). For a common symmetric division, the 
spindle can be found at the cell centre and the pole–pole axis is placed parallel to the cell long 
axis. However, in some cases, the spindle is arranged asymmetrically leading to an asymmetric 
division, which is crucial for development (Connell et al., 2011; Grill et al., 2001; Knoblich, 
2001; Reinsch and Gonczy, 1998). 
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1.2.2 The function of ESCO2 in cell division and viability 
For correct transmission of genetic material during mitosis, chromosomes have to be replicated 
once followed by symmetric distribution between the daughter cells. Cohesin is a multi-subunit 
protein complex crucial for this process. Its core subunits, SMC1A, SMC3, RAD21/SCC1 and 
SCC3 build a ring-like structure (Nasmyth and Haering, 2009). As the name implies, cohesin 
is responsible for cohesion, which means to hold the sister chromatids together until they are 
symmetrically distributed to the two different daughter cells in metaphase (Onn et al., 2008). 
In yeast, the acetyltransferase ECO1 (establishment of cohesion 1) is required for 
tethering of sister chromatids (Toth et al., 1999). ECO1 acetylates SMC3 at the positions K112 
and K113 and is crucial for viability in yeast (Brands and Skibbens, 2005; Zhang et al., 2008). 
Two ECO1 orthologues were identified in mammals, ESCO1 and ESCO2 
(establishment of sister chromatid cohesion N-acetyltransferase 1 and 2) (Bellows et al., 2003; 
Hou and Zou, 2005). A H2C2 zinc finger motif and an acetyltransferase domain make up the 
conserved C-terminal domain of both proteins (Hou and Zou, 2005). The N-terminal domain is 
divergent and crucial for chromosome binding (Hou and Zou, 2005). Both, ESCO1 and ESCO2, 
acetylate SMC3 since only loss of both enzymes decreased SMC3 acetylation (Nishiyama et 
al., 2010). However, both acetylases are functionally not redundant as shown in knockout mice 
and in human cells. In mice, ESCO2 deficiency with normal ESCO1 caused termination of 
development leading to early embryonic death (Whelan et al., 2012b). A defect of sister 
chromatid cohesion was observed causing a prometaphase delay and apoptosis (Whelan et al., 
2012b). In human cells, loss of either enzyme, ESCO1 or ESCO2, led to an increase of defective 
cohesion (Hou and Zou, 2005). 
Altogether, the non-redundant function of ESCO2 in chromatid cohesion is essential for 
cell viability and organism development. The important role of ESCO2 is further reflected in 
human diseases.  
 
1.3 Role of ESCO2 in human malformation syndromes 
Two diseases are known to be caused by mutations of ESCO2: Roberts syndrome and Juberg-
Hayward syndrome. 
 
1.3.1 Roberts syndrome (RBS) 
Roberts syndrome (RBS) is a disorder transmitted autosomal recessively and defined by 
microcephaly, pre- and postnatal growth retardation, cleft lip/palate, and either absence of all 
four limbs (tetraphocomelia) or severe limb reduction often accompanied with digit 
malformations (ectrodactyly and syndactyly) (Freeman et al., 1974; Van Den Berg and Francke, 
1993). Besides, other abnormalities, like cardiac defects or corneal opacities leading to loss of 
vision, are common (Vega et al., 2010). Severely affected individuals often die during 
pregnancy or shortly after birth, whereas individuals with a milder form of RBS, also known as 
SC phocomelia, usually reach adulthood (Schule et al., 2005; Vega et al., 2010). The degree of 
cognitive impairment varies distinctly (Vega et al., 2010). 
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In 2005, Esco2 was identified as the causative gene for RBS (Vega et al., 2005). So far, 
30 different mutations in Esco2 were identified in RBS patients (Gordillo et al., 2008; Mengen 
et al., 2018; Resta et al., 2006; Schneeberger et al., 2020; Schule et al., 2005; Vega et al., 2010; 
Vega et al., 2005). Most of the identified mutations are truncating mutations leading to at least 
partial loss of the acetyltransferase domain (Gordillo et al., 2008; Vega et al., 2010). Small 
deletions or insertions shift the reading frame and create premature stop codons resulting in 
truncated proteins or mRNA instability as the transcripts may be degraded in nonsense-
mediated mRNA decay (Gordillo et al., 2008). Besides, mutations in introns were detected 
leading to aberrant splicing, which finally also results in a truncated protein or reduced mRNA 
amount (Gordillo et al., 2008; Schneeberger et al., 2020). One missense mutation was further 
investigated, which did not lead to a truncated protein and also levels of mRNA and protein 
were normal (Gordillo et al., 2008). A single amino acid of the acetyltransferase domain was 
changed resulting in a reduction of enzymatic activity. As the resulting cellular phenotype was 
undistinguishable to the other mutations, the authors concluded that the loss of ESCO2 
acetyltransferase activity contributes to the pathogenesis of RBS (Gordillo et al., 2008). 
No clear phenotype-genotype correlation was found, as different clinical severities did 
not occur with different kinds of mutations (Schule et al., 2005). However, some mutations 
correlate with the presence of corneal opacities, which in turn is statistically associated with the 
occurrence of mental retardation and cardiac abnormalities (Vega et al., 2010). 
In a karyogram showing the metaphase chromosomes of affected cells, the lack of 
cohesion becomes visible as the centromeres separate prematurely, also known as 
heterochromatin repulsion or puffing (Freeman et al., 1974; German, 1979; Van Den Berg and 
Francke, 1993). These separation defects often results in sporadic aneuploidy (abnormal 
number of chromosomes) in the affected cells (Jabs et al., 1989; Schulz et al., 2008). 
Furthermore, increased cell death was found in RBS cells, which leads to a decreased 
proliferation capacity and was suggested to be responsible for the malformations observed in 
RBS (Gordillo et al., 2008).  
 
1.3.2 Juberg-Hayward syndrome (JHS) 
Juberg-Hayward syndrome (JHS) is an autosomal recessive malformation disorder, marked by 
microcephaly, cleft lip/palate, short stature, ptosis (dropping/falling of the upper eye lid), digit 
malformations (hypoplastic or aplastic thumbs, clinodactyly) and elbow restrictions caused by 
misplacement of the radial head or fusion of the forearm bones (Juberg and Hayward, 1969; 
Kantaputra and Mongkolchaisup, 1999; Kingston et al., 1982; Nevin et al., 1981; Verloes et al., 
1992). 
So far, three JHS patients were reported to be homozygous for the same mutation in 
Esco2 inducing a premature stop codon, which leads to truncation of the 50 C-terminal amino 
acids of the protein affecting the acetylase domain (Kantaputra et al., 2020a; Kantaputra et al., 
2020b). As both disorders, RBS and JHS, are caused by ESCO2 mutations, they are called 
allelic. Interestingly, the disorders share several features, including microcephaly, cleft 
lip/palate, short stature, limb truncation, hypoplastic or aplastic thumbs, clinodactyly and elbow 
flexion contracture (Kantaputra et al., 2020b). In general, the symptoms of JHS are milder than 
in RBS. However, RBS and JHS are still considered as two different disorders since they have 
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not been reported within the same families. Besides, the mutation causing JHS is not found in 
patients with RBS. Thus, a phenotype-genotype correlation was suggested (Kantaputra et al., 
2020a; Kantaputra et al., 2020b).  
In their recent papers, Kantaputra et al suggest explanations for the relatively mild 
phenotype of JHS compared to RBS, although in both disorders, the ESCO2 mutations interfere 
with its acetyltransferase activity (Kantaputra et al., 2020a; Kantaputra et al., 2020b). The 
Arg552Ter mutation generates the stop codon-containing sequence UGACUG, which was 
found to have a high read-through rate meaning that spontaneous read-through events might 
lead to a full-length protein (Cridge et al., 2018; Kantaputra et al., 2020a). However, in 
mammalian cell culture, the Arg552Ter mutation resulted in only a truncated protein and no 
full-length protein was detected in Western Blot (Kantaputra et al., 2020b). In another 
explanation, the remaining truncated protein may still fulfill non-acetyltransferase functions of 
the N-terminal domain to a higher extent than in RBS (Kantaputra et al., 2020b). Furthermore, 
expression of other genes may affect the severity of symptoms, which could also explain the 
phenotypic variability seen in individuals with the same ESCO2 mutation (Kantaputra et al., 
2020b). 
 
1.4 The exosome complex regulates gene expression post-transcriptionally 
1.4.1 Regulation of gene expression 
The genetic material of the somatic cells from one organism is equal but the tasks those various 
types of cells have to fulfil are highly diverse, making regulation of gene expression 
indispensable. The regulation occurs on different levels. Divers mechanisms regulate how much 
RNA is transcribed from a gene, how much of this is translated into protein and how long this 
protein is stable and how active it is.  
Several mechanisms are known to regulate gene expression already on the level of 
DNA. DNA methylation, histone modifications and chromatin modifications determine which 
genes will be transcribed into RNA as they influence the accessibility of regulatory elements to 
transcription factors. Transcription factors bind to DNA sequences specifically and can promote 
or repress the transcription of a gene. Some transcription factors are master regulators in cortical 
development. Frequently, their expression is specific to a certain cell type. For example, PAX6 
is a typical marker for RGCs. Several studies showed that PAX6 is essential for neurogenesis 
(Estivill-Torrus et al., 2002; Heins et al., 2002; Muzio et al., 2002). As the cells migrate into 
the SVZ, they progressively loose PAX6 and start to express TBR2 (also known as EOMES), 
which is associated with IPC identity (Englund et al., 2005). 
One example for chromatin modifiers, are the ATP-dependent BAF (SWI/SNF) 
complexes. BAF complexes utilize ATP to change highly condensed heterochromatin into 
accessible euchromatin. By controlling chromatin state, BAF complexes regulate global gene 
expression programs (Narayanan et al., 2015). They consist out of at least 15 different subunits, 
including invariant core subunits (BAF47, BAF155, BAF170), two interchangeable core 
ATPase subunits (Brg1 or Brm), and lineage-specific subunits (Lessard et al., 2007). By the 
combination of different subunits, hundreds of different BAF complexes can be formed (Ronan 
et al., 2013), specific for e.g. neural progenitors, neurons, oligodendrocytes or Schwann cells. 
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These complexes are crucial for cell-type specific gene expression (Narayanan and Tuoc, 2014). 
By this, BAF complexes regulate the differentiation of neural progenitor cells into distinct 
neuronal subtypes (Narayanan and Tuoc, 2014). BAF complexes are known to be essential for 
controlling gene transcription; however, it has not been investigated yet whether BAF 
complexes are important for post-transcriptional regulation as well. 
Post-transcriptional mechanisms control the amount of protein translated from RNA via 
regulating RNA stability, splicing and transport. RNA can be modified by the addition of a 
certain chemical group, for example a methyl or acetyl group, to a specific position on the RNA. 
Proteins that transfer such a chemical group onto RNA are called writer proteins. Reader 
proteins can bind RNA and recognize these modifications specifically, which, in turn, can be 
removed by eraser proteins (Yang et al., 2018).  
The most investigated RNA modification is the methylation of nitrogen 6 in adenosine 
(m6A). The m6A writer complex consists of RBM15, WTAP, METTL3 and METTL14 and 
can add methyl groups to RNA (Liu et al., 2014; Wang et al., 2016). Being an m6A eraser, 
Alkbh5 detaches these methyl groups (Zheng et al., 2013). YTH proteins and eIF3 function as 
m6A readers to detect m6A (Meyer et al., 2015; Patil et al., 2016; Wang et al., 2014). Recent 
studies indicate essential functions of m6A methylation in the control of RNA stability in the 
development of the brain (Flamand and Meyer, 2019; Wang et al., 2018; Widagdo and 
Anggono, 2018; Yoon et al., 2017). Notably, m6A was reported to affect not only RNA stability 
but also translation, splicing and transport (Dominissini et al., 2012; Kasowitz et al., 2018; 
Meyer et al., 2012; Wang et al., 2015; Xiao et al., 2016). 
Next to m6A, about 170 other types of RNA modifications have been reported 
(Boccaletto et al., 2018; Helm and Motorin, 2017; Nachtergaele and He, 2018). For example, 
several studies showed that N6,2′-O-dimethyladenosine (m6Am), pseudouridine (Ψ), 5-
methylcytidine (m5C), N4-acetylcytidine (ac4C) and 8-oxo-7,8-dihydroguanosine (8-oxoG) 
affect stability of RNA (reviewed by Boo and Kim, 2020).  
Enzymes that degrade RNAs are called ribonucleases and can be divided into three 
classes; endonucleases, which cut the RNA internally, and 3’ and 5’ exonucleases, which 
hydrolyse RNA from the 3’ or 5’ end, respectably (Houseley and Tollervey, 2009). The 3’ 
exonuclease EXOSC10 and DIS3, which possess endonuclease and 3’ exonuclease activity, 
belong to the exosome complex, the main eukaryotic ribonuclease complex, which is further 
described in the next section. The other group of ribonucleases in eukaryotic cells are the XRN 
exonucleases (Tatosyan et al., 2020). XRN exonucleases are the main 5’ exonucleases and 
include the cytoplasmic XRN1 and nuclear XRN2, whose functions in general RNA turnover, 
rRNA maturation, nonsense-mediated decay (NMD) and termination of transcription have been 
shown to be indispensable in various species (Nagarajan et al., 2013). 
Post-translational mechanisms control the activity and stability of proteins. For instance, 
small molecules, like amino acids or nucleotides, can bind to a protein and thereby change its 
conformation (Fischer et al., 2015). This conformational change can affect a protein function. 
Similarly, also protein-protein interactions can lead to a conformational change (Goh et al., 
2004). This type of regulation is most obvious in protein complexes in which structural subunits 
modify the function of the catalytic subunits. Besides, also protein phosphorylation can alter 
protein function (Cohen, 1982; Rubin and Rosen, 1975; Ubersax and Ferrell, 2007). Protein 
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kinases typically transfer a phosphate group from ATP to a hydroxyl group of a serine, 
threonine or tyrosine residue (Hunter, 1995; Rubin and Rosen, 1975). Protein phosphatases can 
reverse this process by hydrolysis of a phosphorylated residue (Hunter, 1995; Rubin and Rosen, 
1975).  
Two major protein degradation pathways control the stability of proteins, the ubiquitin-
proteasome pathway and lysosomal proteolysis. The addition of multiple ubiquitins targets 
proteins for subsequent degradation. The proteasome detects and degrades these 
polyubiquinated proteins (Callis, 1995; Hochstrasser, 1995; Koepp, 2014). Lysosomes are 
cellular organelles containing proteases and other digestive enzymes. Lysosomes take up 
proteins for degradation by the fusion with autophagosomes, vesicles formed by the enclosure 
of small areas of the cytoplasm in membranes originated from the endoplasmic reticulum 
(Bohley and Seglen, 1992; Huber and Teis, 2016). 
 
1.4.2 The exosome complex composition and its subunits 
The evolutionary conserved RNA exosome complex is a crucial modulator of gene expression 
in developmental processes (Januszyk and Lima, 2014; Kilchert et al., 2016). Even though, an 
exosome complex core with a similar architecture is also found in bacteria and archaea, the 
complex composition described here refers to the eukaryotic exosome complex. The exosome 
complex is structured in a ring-like fashion with eleven different subunits, including nine 
structural subunits (EXOSC1-9) and two catalytic subunits (EXOSC10, DIS3) (reviewed by 
Januszyk and Lima, 2014; Kilchert et al., 2016; Liu et al., 2006).  
The structural subunits build up a core consisting out of a cap formed by EXOSC1-3 
and a hexameric ring structure formed by heterodimers of EXOSC4-9 (Liu et al., 2006; 
Lorentzen et al., 2005; Makino et al., 2013). The trimeric cap subunits EXOSC1-3 carry S1 
and/or KH domains facilitating RNA binding (Allmang et al., 1999; Aloy et al., 2002; Januszyk 
and Lima, 2010; Symmons et al., 2000). The ring subunits EXOSC4-9 harbor PH1 and/or PH2 
domains mediating protein-protein binding and thereby carrying out an essential structural role 
(Liu et al., 2006; Schaeffer et al., 2009). Additionally, the PH domains were also shown to 
mediate sequence-specific RNA binding (Anderson et al., 2006). In connection with the 
structural elements, EXOSC10 and DIS3 can break down various RNAs using their 
ribonuclease activity. Both are functioning as exonucleases with DIS3 harboring an additional 
endonuclease activity (Lebreton et al., 2008; Lorentzen et al., 2008; Schaeffer et al., 2009; 
Schneider et al., 2009). Next to its exoribonuclease domain (EXO), EXOSC10 also holds a 
PMC2NT (polycystin 2 N-terminal) domain, which interacts with the nucleic acid binding 
protein C1D, and a helicase and HRDC (RNase D C-terminal) domain than can bind RNA (Liu 
et al., 1999; Stead et al., 2007). The catalytically active domains of DIS3 are the RNB 
(ribonuclease B) and the PIN (PiLT N-terminal) domain carrying the endonuclease activity 
(Frazao et al., 2006; Mian, 1997; Schneider et al., 2009). Additionally, DIS3 contains the 
functionally important CR3 motif, two cold shock domains and a C-terminal S1 domain (Frazao 
et al., 2006; Schaeffer et al., 2012). 
Different names are in use for the subunits of the eukaryotic exosome complex, for 
example, EXOSC10 is also known as RRP6 (Ribosomal RNA-processing protein 6) and DIS3 
 10  
 
as RRP44, which originate from the terms of the yeast genes. Here, I use the names from the 
human homologs. 
The exosome complex conducts RNA processing and decay in the cytoplasm and the 
nucleus, including the nucleolus (Butler and Mitchell, 2011; Schaeffer et al., 2011; Schneider 
and Tollervey, 2013). The cytoplasmic exosome consists out of the 9 subunit core and DIS3, 
the nucleolar exosome contains EXOSC10 instead of DIS3 and in the nucleus both nucleases 
are associated with the core  (Januszyk and Lima, 2014; Tomecki et al., 2010). In humans, three 
versions of DIS3 were identified, named hDIS3, hDIS3L and hDIS3L2 (Malecki et al., 2013; 
Staals et al., 2010; Tomecki et al., 2010). hDIS3 associates with the exosome complex core in 
the nucleus together with EXOSC10, whereas DIS3L is the catalytic subunit of the cytoplasmic 
exosome complex (Tomecki et al., 2010). DIS3L2 is found in the cytoplasm without connection 
to the exosome complex (Malecki et al., 2013).  
In the nucleus, DIS3 and EXOSC10 appear to be co-dependent since EXOSC10 has 
been shown to stimulate DIS3 exo- and endonucleolytic activity and EXOSC10 activity relies 
on DIS3 exonucleolytic activity (Gudipati et al., 2012; Schneider et al., 2012). Additionally, 
the exo- and endonucleolytic activities are also dependent on the core (Wasmuth and Lima, 
2012). 
The cytoplasmic, the nuclear and the nucleolar complexes associate with different sets 
of cofactors. The structural subunits interact with their cofactors through composite surfaces 
enabling the exosome complex to target specific RNAs. Thereby, the subunits deliver 
functional specificity (Januszyk and Lima, 2014; Lubas et al., 2011). Hence, the entire exosome 
complex is indispensable for regulating RNA quantities and eliminating defective RNAs. 
 
1.4.3 The exosome complex functions and its cofactors 
The exosome complex is responsible for general mRNA degradation and thereby regulating 
protein-synthesis rates. For instance, in human cells, the exosome complex is recruited to 
transcripts harboring AU-rich sequence elements (AREs) (Chen et al., 2001; Kilchert et al., 
2016; Mukherjee et al., 2002; Tran et al., 2004). These are present in short-lived human mRNAs 
coding for proteins with transient expression, including growth factors and proto-oncogenes. 
An important cofactor for cytoplasmic mRNA degradation by the exosome complex is the SKI 
(Superkiller) complex formed by SKI2, SKI3 and SKI8 (Anderson and Parker, 1998). Their 
human homologs are SKIV2L, TTC37 and WDR61, respectively. SKI2 is an RNA helicase and 
SKI3 and SKI8 contain structural motifs known to be relevant for protein-protein interactions 
(Halbach et al., 2013). In yeast, the SKI complex and the exosome complex were shown to form 
a joint continuous channel directing the RNA from the helicase to the nuclease (Halbach et al., 
2013). 
The exosome complex is also part of RNA quality control by breaking down improperly 
processed or defective mRNAs. The exosome complex performs nonsense-mediated decay 
(NMD) by the turnover of transcripts carrying premature termination codons, nonstop decay 
(NSD) by degrading transcripts missing termination codons and no-go-decay (NGD) by the 
decay of transcripts in which translation has stalled (Doma and Parker, 2006; Houseley et al., 
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2006; Lejeune et al., 2003; Mitchell and Tollervey, 2003; Schaeffer et al., 2011; Takahashi et 
al., 2003; van Hoof et al., 2002). 
Despite degrading mRNA in the cytoplasm, the exosome complex degrades pre-mRNAs 
already in the nucleus. For example, also inefficiently spliced pre-mRNA is degraded by the 
exosome complex (Kilchert et al., 2015). The transcripts may retain “decay-promoting” introns 
containing sequences that promote binding of the exosome specificity factor Mmi1 inducing 
degradation by the exosome complex. Fast splicing of introns harboring Mmi1-binding sites 
prevents the decay. Increased intron retention resulting in low gene expression was shown to 
be a response to stress in yeast (Kilchert et al., 2015).  
The exosome complex also processes noncoding RNAs (ncRNAs). A crucial function 
in the processing of ribosomal RNA (rRNA) was reported already in the nineties showing that 
the exosome complex is required for 3’ processing of 7S pre-rRNA to 5.8S rRNA (Mitchell et 
al., 1997; Mitchell et al., 1996). The exosome complex was also found to be involved in the 
maturation and surveillance of small nuclear RNA (snRNA) and small nucleolar RNA 
(snoRNA) (Allmang et al., 1999; van Hoof et al., 2000). Defective precursors of transfer RNA 
(tRNA), ribosomal RNA (rRNA), snRNA and snoRNA are targeted and polyadenylated by the 
TRAMP (TRF4/5-AIR1/2-MTR4 Polyadenylation) complex, which then activates the exosome 
complex (Kadaba et al., 2004; Kadaba et al., 2006; Schneider et al., 2012; Vanacova et al., 
2005). The TRAMP complex consists out of the poly(A)-polymerase TRF4 or TRF5, the RNA 
helicase MTR4 and the RNA-binding proteins AIR1 and AIR2 and is a key nuclear cofactor of 
the exosome complex as it polyadenylates transcripts to facilitate the hydrolysis by the exosome 
complex (Butler and Mitchell, 2011; LaCava et al., 2005; Vanacova et al., 2005). Besides, the 
exosome complex also breaks down cryptic unstable transcripts (CUTs), which belong to the 
group of unstable ncRNAs (Schneider et al., 2012; Wyers et al., 2005). Another important 
nuclear cofactor of the exosome complex is the NEXT (Nuclear Exosome Targeting) complex, 
involving the RNA helicase MTR4 together with the RNA-binding protein RBM7 and the Zinc-
knuckle containing protein ZCCHC8, which are suggested to be essential for substrate targeting 
(Lubas et al., 2011). The NEXT complex was shown to be required for the degradation of 
promoter upstream transcripts (PROMPTs) by the exosome complex (Lubas et al., 2011). 
PROMPTs are noncoding RNAs found upstream of transcription start sites (Preker et al., 2008). 
Their general functions remain uncertain; however, roles in methylation and regulatory 
purposes were described (Imamura et al., 2004; Lloret-Llinares et al., 2016; Preker et al., 2008). 
All in all, the exosome complex is essential for post-transcriptional processing and 
decay of different RNA types.  
 
1.5 Role of the exosome complex in neurodevelopmental disorders 
Mutations in several exosome subunits have been linked a variety of syndromes affecting 
different tissues including the nervous system. In particular, EXOSC2 mutations have been 
associated to the SHRF (short stature, progressive hearing loss, retinitis pigmentosa and 
distinctive facies) syndrome (Di Donato et al., 2016). Various mutations in EXOSC3, EXOSC8 
and EXOSC9 were identified in patients affected by different types pontocerebellar hypoplasia 
(PCH) (Boczonadi et al., 2014; Burns et al., 2018; Wan et al., 2012). Individuals with mutations 
in EXOSC10 display microcephaly and a global developmental delay often accompanied with 
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motor problems. Mutations in DIS3 have been associated to multiple myeloma, a malignancy 
of mature B-lymphoid cells in the bone marrow (Chapman et al., 2011; Weissbach et al., 2015). 
The syndromes with neurodevelopmental contribution are discussed in more detail below and 
are summarized in Table 1. 
 
 
1.5.1 Pontocerebellar hypoplasia (PCH) 
Pontocerebellar hypoplasia (PCH) is a clinically and genetically diverse group of rare 
neurodegenerative diseases defined by progressive atrophy of various parts of the brain and a 
global developmental delay (Namavar et al., 2011). Various types of PCH caused by different 
gene mutations have been reported. PCH types 1b, 1c and 1d have been linked to mutations of 
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Table 1. Mutated components of the RNA exosome complex in human mental disorders
RRP4
short stature; progressive hearing loss; retinitis 
pigmentosa; distinctive facies; premature 
ageing; mild intellectual disability
atrophy of pons and cerebellum; microcephaly; 
severe developmental delay; muscle atrophy 







progressive spastic paraplegia; cerebellar 
atrophy; strabismus; mild cognitive symptoms
RRP43
RRP45
(Biancheri et al., 
2013; Di 
Giovambattista et 
al., 2017; Eggens et 
al., 2014; Ivanov et 
al., 2018; Le Duc et 
al., 2020; Rudnik-





 + various null 
mutations
(Halevy et al., 2014; 
Zanni et al., 2013).
(Boczonadi et al., 
2014)
cerebellar and corpus callosum hypoplasia; 
hypomyelination; spinal muscular atrophy 
(SMA); severe muscle weaknes; psychomotor 
deficit; respiratory impairment
(Bizzari et al., 2020; 
Burns et al., 2018; 
Sakamoto et al., 
2020)
(Ulmke et al., in 
reparation)
PCH1c
progressive SMA-like motor neuronopathy; 
cerebellar atrophy with normal pons; 
progressive muscle weakness; severe 
developmental delay; sometimes respiratory 
impairment 
EXOSC10
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PCH1b 
In PCH1b, pontine and cerebellar atrophy are observed starting at birth together with 
abnormalities of Purkinje cells and degeneration of spinal motor neurons, which manifests in 
microcephaly, developmental delay and muscle atrophy and weakness (Wan et al., 2012). More 
than 60 PCH1b patients with an EXOSC3 mutation were described. Thereby, several 
pathogenic missense variants of EXOSC3 in which one amino acid is exchanged were found: 
G31A, V80F, Y109N, D132A, G135E, A139P, G191C and W238R (Biancheri et al., 2013; Di 
Giovambattista et al., 2017; Eggens et al., 2014; Ivanov et al., 2018; Le Duc et al., 2020; 
Rudnik-Schoneborn et al., 2013; Saugier-Veber et al., 2020; Schottmann et al., 2017; 
Schwabova et al., 2013; Wan et al., 2012). PCH1b patients were reported to carry missense 
variants in homozygous condition or in combination with another pathogenic variant 
(compound heterozygous condition). This second pathogenic variant can be either another 
missense variant or a null mutation meaning a loss-of-function mutation, e.g. by a frameshift 
or whole exon deletions (Eggens et al., 2014; Rudnik-Schoneborn et al., 2013). Heterozygous 
individuals with one healthy allele were not affected (Rudnik-Schoneborn et al., 2013). 
Complete loss-of-function of EXOSC3 by a homozygous null mutation was not observed and 
therefore suggested to be embryonically lethal (Rudnik-Schoneborn et al., 2013). 
The different EXOSC3 variants and their different combinations observed vary in the 
disease severity, mainly defined by the age of death. For example, individuals homozygous for 
the G31A variant were reported to have a life expectancy between 4 days to 17 months, whereas 
D132A homozygous individuals had a lifespan of 5 to 18 years (Biancheri et al., 2013; Eggens 
et al., 2014; Ivanov et al., 2018; Rudnik-Schoneborn et al., 2013; Schottmann et al., 2017; 
Schwabova et al., 2013; Wan et al., 2012). Besides, the variant combinations V80F/D132A and 
homozygous G191C were only linked to hereditary spastic paraplesia without typical PCH1b 
symptoms (discussed later in this section). Thus, a genotype-phenotype correlation was 
suggested (Eggens et al., 2014; Rudnik-Schoneborn et al., 2013). 
However, also for the same pathogenic variant composition, the clinical manifestations 
may differ. For instance, the combination of D132A and G191 variants was reported in two 
siblings exhibiting different severities of PCH1b with one sibling showing a prenatal-onset of 
disease and never reaching developmental milestones and the other with a postnatal disease 
onset and delayed psychomotor development but still reaching all milestones (Le Duc et al., 
2020). The first sibling was the only one displaying hypotonia and muscle atrophy. Further, the 
cognitive impairment varied from severe intellectual disability in the first sibling to merely 
learning disabilities in the other one. Another example for clinical variations is the G31A 
homozygous genotype. Previous studies associated G31A homozygosity with a severe PCH1b 
phenotype (Di Giovambattista et al., 2017; Eggens et al., 2014; Rudnik-Schoneborn et al., 2013; 
Schwabova et al., 2013; Wan et al., 2012). More recently, G31A homozygous patients were 
described with aspinal muscular atrophy (SMA)-like phenotype lacking hypoplasia of pons and 
cerebellum in the first months of life (Ivanov et al., 2018). Besides, two G31A homozygous 
fetuses have been reported displaying microlissencephaly (microcephaly with a smooth brain 
surface) and rhombencephalosynapsie (malformation of the cerebellum with agenisis of the 
vermis and fusion of cerebellar hemispheres), which were not mentioned with PCH1 before 
(Saugier-Veber et al., 2020). These studies cast doubt on the proposed clear genotype-
phenotype correlation. Instead, other factors were suggested to be involved in the resulting 
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phenotype. The individual genetic architecture could influence the course of disease. Additional 
genetic variants missed in exome sequencing may cause a more severe phenotype or variants 
crucial for maintenance of cellular functions could contribute to a milder phenotype (Le Duc et 
al., 2020). In addition, epigenetic alterations and the gender could have an impact (Le Duc et 
al., 2020). 
Studies in model organisms further support the finding that EXOSC3 missense variants 
identified in PCH1b patients diminish the function of the exosome complex. Depletion of 
EXOSC3 in zebrafish embryos leads to hindbrain shrinkage, which can be rescued by wild-
type zebrafish EXOSC3 mRNA (Wan et al., 2012). However, mutant zebrafish EXOSC3 
mRNA resembling the human variants G31A, D132A and W238R, could not improve the 
hindbrain defect (Wan et al., 2012). In addition, in mouse neuronal cell line, the expression 
levels of mouse EXOSC3 mRNA corresponding to the G31A and W237R variants were lower 
than wild-type EXOSC3 expression levels (Fasken et al., 2017). These finding suggests that the 
amino acid alterations interfere with folding of the EXOSC3 protein. 
Investigations of the exosome complex structure indicate that the G31, D132, and W238 
residues of EXOSC3 might be relevant for interactions with EXOSC5 and EXOSC9 (Fasken et 
al., 2017). The G31 residue in the N-terminal domain of EXOSC3 is tightly wrapped close to 
EXOSC5. Thus, the G31A variation could affect the association with EXOSC5 (Fasken et al., 
2017). The D132 residue is positioned in a loop between strands of the EXOSC3 S1 domain. 
Hence, the D132A variation might hamper folding of the loop and interfere with interactions 
of EXOSC3 with EXOSC5 and EXOSC9 (Fasken et al., 2017). The W238 residue is located in 
a pocket between the S1 and KH domains and may be important for the correct positioning of 
residues to interact with EXOSC9. Thereby, the W238R mutation could impair interactions 
with EXOSC9 (Fasken et al., 2017). Altogether, the amino acid substitutions in EXOSC3 linked 




22 individuals from three families diagnosed with PCH1c were reported with a mutation in 
EXOSC8, characterized by cerebellar and hypoplasia of cerebellum and corpus callosum, spinal 
muscular atrophy (SMA) and hypomyelination starting at birth (Boczonadi et al., 2014). 
Clinically, the patients present psychomotor deficit, impaired vision and hearing and severe 
muscle weakness, typically leading to death in the first years by respiratory failure. Similar to 
PCH1b-affected individuals, PCH1c-affected patients show impairments in spinal motor 
neurons and Purkinje cells. Additionally, they display defects in oligodendroglia causing 
hypomyelination (Boczonadi et al., 2014).  
Two different homozygous mutations of EXOSC8 were found in the affected 
individuals, both altering conserved amino acids (A2V and S272T) (Boczonadi et al., 2014). 
The A2V mutation is associated with a less severe PCH1c with a slightly longer lifespan of 
≥2.3 years instead of ≤2 years in the S272T mutation.  
Structural analysis revealed that the S272 residue is positioned in the PH domain and 
could be crucial for interaction with EXOSC9 or affect opening of the RNA channel (Boczonadi 
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et al., 2014; Liu et al., 2006; Morton et al., 2018). The A2 residue could be relevant for the 
interaction with EXOSC1 or affect an opening located at the side of the exosome complex (Liu 
et al., 2006; Morton et al., 2018). Despite potentially affecting the interaction and function of 
EXOSC8, both mutations lead to a decreased amount of EXOSC8 protein (Boczonadi et al., 
2014). Interestingly, in cells from EXOSC8 patients, also reduced levels of EXOSC3 protein 
were identified suggesting a close interaction between both exosome complex subunits 
(Boczonadi et al., 2014). 
Upregulated mRNA levels of the ARE-containing myelin proteins MBP and MOBP 
were found in patient myoblasts (Boczonadi et al., 2014). These findings could be repeated in 
human oligodendroglia cells upon downregulation of EXOSC8 by siRNA. The authors suggest 
that a disturbed balance between myelin components may cause the demyelinating disease. 
Similarly, defective myelination was described in EXOSC8 knockdown zebrafish (Boczonadi 
et al., 2014). An initial increase of myelin proteins was observed. The loss of oligodendroglia 
then lead to a decrease of myelin proteins later.  
Additionally, in patient fibroblasts, SMN1 expression was increased, which is 
associated with SMA (Boczonadi et al., 2014). Notably, patient fibroblasts also show an 
increase of developmental HOX mRNA levels and the epigenetic regulator HOTAIR long 
ncRNA levels, similar to RBM7 mutant fibroblasts (Giunta et al., 2016). Levels of other ARE 
and non-ARE mRNAs were tested in patient cells as well as cells in which EXOSC8 was 
downregulated by siRNA. No general change in other mRNA levels was detected indicating 
only specific transcripts to be affected by EXOSC8 dysfunction (Boczonadi et al., 2014). 
Taken together, the EXOSC8 mutation in PCH1c-affected patients seems to diminish 
exosome complex function, causing accumulation of specific transcripts, like HOX, SMN1 and 
myelin-related mRNAs, which finally impairs neurodevelopment and myelin synthesis. 
 
PCH1d 
The disorder associated with EXOSC9 mutations was reported as PCH-like or PCH1d (Bizzari 
et al., 2020; Burns et al., 2018; Sakamoto et al., 2020). 
Three missense mutations (L14P, G51R and L80R) and two truncating mutations, 
including one nonsense mutation (R161X) and a frameshift mutation leading to an early stop 
codon (R162KfsX3), were identified (Burns et al., 2018; Sakamoto et al., 2020). The L14 
residue is placed in the first alpha helix of EXOSC9 as shown by structure analysis and the 
mutation could disturb intramolecular interactions of the protein (Fasken et al., 2020; Liu et al., 
2006). The other missense mutations are within the first PH domain (Sakamoto et al., 2020). A 
disruption of the PH domain could interfere with the sequence-specific RNA binding of the 
exosome complex (Anderson et al., 2006). 
So far, nine individuals were reported with an EXOSC9 mutation, either homozygous 
for a missense mutation or compound heterozygous with a missense and a truncating mutation. 
In particular, five patients have been revealed homozygous for the L14P variant, one 
heterozygous for L14P and R161X, one homozygous for G51R, two heterozygous for L80R 
and R162KfsX3 (Bizzari et al., 2020; Burns et al., 2018; Sakamoto et al., 2020).  
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The affected individuals show a neurodegenerative disorder with early-onset, 
progressive SMA-like motor neuronopathy and atrophy of the cerebellum (Bizzari et al., 2020; 
Burns et al., 2018; Sakamoto et al., 2020). Similar to patients with EXOSC3 or EXOSC8 
mutations, the affected individuals all show progressive muscle weakness and severe 
developmental delay. Some also show respiratory impairment (Burns et al., 2018). Unlike 
EXOSC3/EXOSC8 mutation patients, they display a relatively normal pons (Bizzari et al., 
2020; Burns et al., 2018; Sakamoto et al., 2020). One  individual with compound heterozygous 
EXOSC9 mutations (L14P and R161X) showed a more severe form and died of respiratory 
failure at 15 months, whereas the homozygous L14P patients were alive at the ages of 19 
months, 28 months, 3 years, 4.5 years and 4 years and 7 months, respectively (Bizzari et al., 
2020; Burns et al., 2018). Besides, this individual also showed congenital fractures of the long 
bones (Burns et al., 2018).  
Individuals compound heterozygous for L80R and R162KfsX3 variants exhibit similar 
disease characteristics as the other patients with EXOSC9 variants, however, both individuals 
showed slight intellectual development, with one being able to read some words and the other 
to participate in a basic conversation (Sakamoto et al., 2020). The clinical difference between 
individuals harboring different missense variants of EXOSC9 indicates a genotype-phenotype 
correlation. 
Patient derived fibroblasts homozygous for the L14P variant showed a reduction of 
EXOSC9 expression compared to controls (Burns et al., 2018). In skeletal muscle from the 
patient with heterozygous EXOSC9 mutations (L14P and R161X), protein levels were even 
lower matching the more severe phenotype (Burns et al., 2018). Interestingly, in patient 
fibroblasts expressing reduced levels of the EXOSC9-L14P variant, EXOSC3 and EXOSC8 
levels were normal, whereas in cells with reduced levels of the EXOSC3-G31A or EXOSC8-
A2V variant, amounts of other exosome complex subunits were reduced (Burns et al., 2018). 
Hence, in contrast to the investigated mutations of EXOSC3 and EXOSC8, the L14P variant of 
EXOSC9 may not destabilize the whole exosome complex. However, the EXOSC9-L14P 
fibroblasts showed a reduced amount of EXOSC3 within the exosome complex (Burns et al., 
2018). Thus, the EXOSC9-L14P variant seems to impair the exosome complex by interfering 
with the association of different subunits within the complex, potentially altering the formation 
of the entire complex (Burns et al., 2018; Fasken et al., 2020). 
RNA sequencing analysis of patient derived fibroblasts homozygous for the EXOSC9-
L14P variant revealed upregulation of many ARE-containing transcripts (Burns et al., 2018). 
Many differently expressed mRNAs are associated with neuronal system development. 
Besides, levels of developmental HOXC8 mRNA were increased. In contrast to observations 
in EXOSC8 and RBM7 mutant cells, levels of the epigenetic regulator HOTAIR ncRNA levels 
were unchanged (Burns et al., 2018; Giunta et al., 2016). RNA sequencing of skeletal muscle 
from the individual with heterozygous EXOSC9 mutations (L14P and R161X) revealed 
changes in the levels of transcripts related to motor neuronopathy and bone disease (Burns et 
al., 2018). Comparison of RNA expression in fibroblasts and in muscle show a low overlap of 
differently expressed transcripts indicating tissue-specific roles of EXOSC9 mutations (Burns 
et al., 2018). 
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1.5.2 Hereditary spastic paraplegia (HSP) 
Hereditary spastic paraplegia (HSP) is a heterogeneous group of neurodegenerative motor 
system diseases defined by a progressive spasticity of the lower limps accompanied by diverse 
additional symptoms (Fink, 2003). 
Four patients diagnosed with HSP were identified to carry a homozygous EXOSC3 
mutation (G191C) (Halevy et al., 2014). The individuals show progressive spastic paraplegia 
with cerebellar atrophy and strabismus. The patients present signs of cerebellar dysfunction, 
like nystagmus (involuntary eye movement) or dysmetria (lack of coordination of movement). 
They also display variable but generally mild cognitive symptoms, including speech delay or 
attention deficit disorder. Typical symptoms for PCH, like microcephaly, hypotonia, respiratory 
impairment, atrophy of the pons or defective myelination were not observed. 
Two patients fitting into the wide range of HSP with delayed motor milestones, 
progressive spasticity and mild cognitive impairment were reported to be compound 
heterozygous for two EXOSC3 missense variants, V80F and D132A (Zanni et al., 2013). 
Similar as for the individuals with the G191C variant of EXOSC3, cerebellar atrophy was 
reported with preserved brainstem and pons. In contrast to the others, V80F/D132A compound 
heterozygous patients also showed indications of lower motor neuron dysfunction, like tongue 
atrophy and fasciculations. 
These studies indicate that EXOSC3 mutations cannot only cause a PCH1 phenotype, 
but also a form of HSP without pontine hypoplasia or atrophy. 
 
1.5.3 SHRF syndrome 
Three individuals were reported with a novel syndrome characterized by a short stature, 
progressive hearing loss, retinitis pigmentosa and distinctive facies (SHRF). Besides the 
patients also displayed premature skin ageing and mild intellectual impairment. Whole exome 
sequencing demonstrated homozygous (Gly30Val) or compound heterozygous (Gly30Val and 
G198A) missense mutations of the gene coding for EXOSC2 (Di Donato et al., 2016). 
Structural modeling of the exosome complex structure suggests that the G30V 
substitution in EXOSC2 could weaken interactions with EXOSC4 (Di Donato et al., 2016). The 
G198 residue is placed at the end of a β-strand in the KH domain of EXOSC2. The G198D 
variant may truncate and impair the β-hairpin structure and thereby interfere with the structure 
of EXOSC2 (Di Donato et al., 2016). 
Comparing the phenotypes of the affected individuals to the disease caused by mutations 
of EXOSC3 or EXOSC8, only a minimal overlap of clinical features is detectable. In the 
EXOSC2 mutant individuals, only borderline or no atrophy of the cerebellum and no indications 
for neurodegeneration were observed, even though the highest level of EXOSC2 expression is 
found in the cerebellar hemispheres (Di Donato et al., 2016). Thus, the authors conclude that 
the loss of EXOSC2 function in neurons might be compensated by other subunits of the 
exosome complex, like EXOSC3, but not vice versa (Di Donato et al., 2016).  
Next to cell-type-specific compensation mechanisms, also different substrate specifity 
conferred by different complex subunits can be a possible explanation of the striking differences 
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in diseases caused by EXOSC2 or EXOSC3 mutations. Indeed, investigation of RRP4-G226D 
mutant yeast cells modelling the human EXOSC2-G198A variant revealed different RNA 
targets compared to a yeast model of the human EXOSC3-W238R variant associated with 
PCH1b (Sterrett, 2020). RRP4-G226D cells display a growth defect, which is worsened by the 
deletion of Mpp6, a cofactor of the exosome complex (Sterrett, 2020). This effect was not seen 
in RRP40-W195R cells modelling the human EXOSC3 mutation (Sterrett, 2020). Mpp6 
stabilizes the interaction between the exosome complex and the RNA helicase MTR4 (Falk et 
al., 2017). Therefore, the authors suggest that the G226D amino acid substitution could cause 
a destabilization of the critical interaction of MTR4 and the exosome complex (Sterrett, 2020). 
How the mutations impede exosome complex function, was further investigated in 
patient-derived lymphoblasts (Yang et al., 2020). The G198D but not G30V variation impairs 
EXOSC2 protein stability with EXOSC2-G198D having a reduced half-life. Further, 
interactions of EXOSC2 with other RNA exosome components were affected as shown by co-
immunoprecipitation. Additionally, protein levels of EXOSC3 and EXOSC10 were decreased 
in G198D mutation-carrying samples compared to samples containing only the G30V mutation. 
Because SHRF patients show premature skin aging, the effect of EXOSC2 loss on primary 
human keratinocytes was investigated (Yang et al., 2020). Indeed, knockout of EXOSC2 
resulted in a reduced proliferation rate. Whereas, wild-type EXOSC2 and EXOSC2-G30V 
could rescue the cell differentiation defect, transduction with EXOSC2-G198D variant could 
not. Thus, EXOSC2-G198V seems to be a non-functional protein linked to impaired cell 
proliferation, whereas EXOSC2-G30V is a weaker disease allele (Yang et al., 2020). 
A EXOSC2 knockout drosophila model presented impairments in eye development and 
maintenance, and development of the muscle structure and wing veins (Yang et al., 2020). 
Further investigations showed that autophagy was impaired in patient cells, as well as in 
EXOSC2 knockout human keratinocytes and in EXOSC2 knockout drosophila model (Yang et 
al., 2020). In drosophila, overexpression of the transcription factor MITF or of the autophagy 
genes ATG1 and ATG17, controlled by MITF, rescued the eye defects and adult lethal 
phenotypes caused by EXOSC2 knockout (Yang et al., 2020). Rapamycin treatment also 
rescued the lethality in EXOSC2 knockout flies (Yang et al., 2020). Rapamycin inhibits the 
mTOR pathway, which regulates many processes including autophagy, and thereby augments 
mRNA turnover (Albig and Decker, 2001; Martinez-Nunez et al., 2017). Additionally, in RNA 
sequencing analysis of RRP4-G226D yeast cells, expression of several autophagy genes was 
decreased (Sterrett, 2020). Taken together, defective autophagy seems to play a role in SHRF 
pathogenesis. 
The role of EXOSC2 was further investigated in EXOSC2 knockout zebrafish, which 
displayed microcephaly, retinis pigmentosa, loss of spinal motor neurons and myelin deficiency 
(Yatsuka et al., 2020). EXOSC2 knockout resulted in impaired mRNA turnover and an 
imbalance in the nucleotide pool (Yatsuka et al., 2020). Rapamycin treatment improved the 
nucleotide pool imbalance, prolonged survival and partially rescued the neuronal defects in 
EXOSC2 knockout zebrafish (Yatsuka et al., 2020). Notably no decrease of autophagy-related 
mRNA was found (Yatsuka et al., 2020). These results indicate that further examination on the 
role of rapamycin in RNA decay and EXOSC2 deficiency in autophagy is needed. 
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1.5.4 Novel syndrome with microcephaly 
A novel syndrome was associated with mutations in EXOSC10, an exonuclease of the exosome 
complex (Ulmke et al, in preparation). Seven affected individuals were identified so far, 
displaying microcephaly and global developmental delay, often accompanied with motor 
problems, like difficulties with walking and coordination. Cerebellar hypoplasia, a smaller 
corpus callosum and abnormal cortical gyration was found in some patients. 
Whereas patients with PCH1b/c/d, HSP or SHRF carry a homozygous or compound 
heterozygous mutation of an exosome complex subunit, the individuals were identified to carry 
only one disease allele of EXOSC10. Hence, in contrast to the other diseases associated with 
exosome complex malfunction, the inheritance seems to be dominant. Six different missense 
mutations were found (Fig.1.2), with one in the N-terminal PMC2NT domain (P54L), which is 
proposed to interact with the nucleic acid binding protein C1D (RRP47) (Stead et al., 2007). 
The other missense mutations are all placed in the exoribonucleolytic domain (D295A, S321T, 
Q330H, G459S, V568M). One frameshift mutation was identified leading to premature 
termination (G420Pfs).  
Figure 1.2 EXOSC10 and its mutations in patients. Illustration of EXOSC10 with its PMC2NT (polycystin 2 
N-terminal) domain, EXO (exoribonuclease) domain and HRDC (RNase D C-terminal) domain. The identified 
mutations are indicated (six missense and one frameshift mutation) (unpublished data). Created with 
BioRender.com. 
 
1.6 General objectives of the studies 
The specific objectives of the studies presented in chapters 2 and 3 were aimed at identifying 
and investigating molecular mechanisms orchestrating the development of the mammalian 
cerebral cortex and to reveal the molecular mechanisms underlying cortical malformation. 
In the first part of this study (Chapter 2), we decided to focus on IPCs as they are the 
progenitors of the vast majority of neurons in the cortex. Accordingly, mutations in IPC genes 
have been shown to cause malformations like microcephaly (Baala et al., 2007; Glickstein et 
al., 2009). Therefore, we purified IPCs from the developing mouse cortex and established the 
transcriptome profile of IPCs by RNA sequencing, indicating which genes are activated in IPCs 
specifically. Comparing these genes to literature, we identified factors, which are likely to 
control IPC genesis. We chose one of them, ESCO2, for further analysis. 
Recent sequencing analyses of cortical malformations revealed a multifarious genetic 
landscape (Hu et al., 2014; Perenthaler et al., 2019). In our pilot work, we identified novel 
microcephaly-related mutations in a gene encoding EXOSC10, a core subunit of the RNA-
decay exosome complex. In the second part of this work (Chapter 3), we characterized the 
cortical phenotypes of EXOSC10cKO mutants. 
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Chapter 2: Molecular profiling reveals involvement of ESCO2 in 
intermediate progenitor cell maintenance in the developing mouse cortex 
 
All elements in this chapter have already been published in: 
Ulmke, P.A.#, Sakib, M.S.#, Ditte, P.#, Sokpor, G.#, Kerimoglu, C., Pham, L., Xie, Y., Mao, 
X., Rosenbusch, J., Teichmann, U., Nguyen, H.P, Fischer, A., Eichele G., Staiger, J.F., Tuoc 
T. (2021). Molecular Profiling Reveals Involvement of ESCO2 in Intermediate Progenitor Cell 
Maintenance in the Developing Mouse Cortex. Stem cell reports, 16(4), 968-984.  
# Authors with equal contribution. 
 
Personal contributions: I was involved in analyses. 
 
2.1 Summary 
Intermediate progenitor cells (IPCs) are neocortical neuronal precursors. Although IPCs play 
crucial roles in corticogenesis, their molecular features remain largely unknown. In this study, 
we aimed to characterize the molecular profile of IPCs. We isolated TBR2 positive (+) IPCs 
and TBR2 negative (-) cell populations in the developing mouse cortex. Comparative genome-
wide gene expression analysis of TBR2+ IPCs versus TBR2- cells revealed difference in key 
factors involved in chromatid segregation, cell-cycle regulation, transcriptional regulation, and 
cell signaling. Notably, mutation of many IPC genes in human led to intellectual disability and 
caused a wide range of cortical malformations, including microcephaly, and agenesis of corpus 
callosum. Loss-of-function experiments in cortex-specific mutants of ESCO2, one of the novel 
IPC genes, demonstrate its critical role in IPC maintenance, and substantiate the identification 
of a central genetic determinants of IPC biogenesis. Our data provide novel molecular 
characteristics of IPCs in the developing mouse cortex. 
 
2.2 Introduction 
In developing cerebral cortex, IPCs are transit amplifying cells that express the T-box 
transcription factor TBR2 (Hevner, 2019). IPCs are basal derivatives of the multipotent radial 
glial progenitor cells (RGCs) in developing cortex, and they exclusively differentiate into 
glutamatergic neurons. Although IPCs are known to give rise to the majority of cortical neurons 
(Haubensak et al., 2004; Kowalczyk et al., 2009; Miyata et al., 2004; Noctor et al., 2004), the 
molecular factors which drive or maintain the transient proliferative capacity and neurogenic 
properties of TBR2+ IPCs in the SVZ niche remain not fully explored. The identification of the 
gene expression program that governs the genesis and maintenance of IPCs would improve our 
understanding of cortical development, and provide possible protocols to culture IPCs in vitro 
or generate these cortical progenitors by cell reprograming from other cell sources. Moreover, 
a description of the molecular features of IPCs can provide insights into the genes implicated 
in the etiology of pertinent neurological disturbances caused by defective IPC genesis. 
To understand the molecular signatures of cell types in developing cortex, scRNA-seq 
analyses have been employed to provide the molecular identity of cell subtypes, including IPCs 
in mouse (Kawaguchi et al., 2008; Li et al., 2020b; Loo et al., 2019; Telley et al., 2016) and 
 21  
 
human cortex (Fan et al., 2018; Li et al., 2018a; Nowakowski et al., 2017; Pollen et al., 2015; 
Zhong et al., 2018). However, due to the threshold of high-throughput scRNA-seq, profiling 
cell type-specific gene expression is challenging. Comparisons between transcriptome analyses 
from purified cell populations have contributed additionally insightful molecular information 
about cortical cell subtypes (Albert et al., 2017; Amamoto et al., 2020; Arlotta et al., 2005; 
Molyneaux et al., 2015; Pinto et al., 2008). 
In the present study, we used an antibody to label intranuclear TBR2 in single-nuclei 
suspensions isolated from E16.5 mouse cortex, and then sorted the TBR2+ cells (taken as IPCs) 
from the TBR2- cells (taken as non-IPCs). We then identified the expression of IPC-enriched 
genes by RNA-seq. Using high-throughput in situ hybridization (ISH) (Visel et al., 2004), we 
confirmed so far the SVZ-restricted expression of 392 novel IPC genes. The in situ expression 
of these genes are freely available online in an interactive database (https://gp3.mpg.de). A 
comparison of mouse IPC transcriptome and human phenotype annotations suggests that these 
IPC-enriched genes play important roles in cortical development in human as such patients with 
mutation variants display a wide range of cortical malformation and intellectual disability. 
Comparative genome-wide gene expression analysis of TBR2+ IPCs versus TBR2- cells 
revealed changes in key factors for chromatid segregation, cell-cycle regulation, transcription 
regulation and chromatin remodeling. Among them, establishment of sister chromatid cohesion 
N-acetyltransferase 2 (ESCO2) was selected for confirmative studies. The cortex-specific 
mutagenesis for ESCO2 caused a massive depletion of the IPC population, thus validating that 




2.3.1 Sorting and transcriptome profiling of intermediate progenitor cells in developing 
mouse cortex 
To compare the transcriptome profile of TBR2+ IPCs and TBR2- cells in mouse developing 
cortex (Fig. 2.1A), we isolated nuclei and established intranuclear immunofluorescent staining 
and FACS protocol (Fig. 2.1B). We used intranuclear TBR2 antibody labeling in single-nuclei 
suspensions isolated from E16.5 mouse cortices followed by cell sorting (Fig. 2.1C) (Sakib et 
al., 2021). Sorting gates were adjusted to purify TBR2+ IPC and TBR2- cell nuclei. Unlike 
unsorted nuclei suspensions, sorted nuclei suspensions were highly enriched (i.e., >99%) in the 
desired cell type (Fig. 2.1C/D). 
To understand the gene-regulatory difference in these cell populations, we generated 
RNA-seq libraries with three biological replicates for each cell populations. As anticipated, a 
high expression of canonical IPC genes was observed in the IPC population consistent with 
known in vivo expression patterns (Fig. 2.1E-F, Fig. S2.1A-C, Table S1). Comparing the 
expression of housekeeping genes, which locate on chromosome X (Xist, Pgk1, Hprt, Eif2s3x) 
and chromosome Y (Ddx3y, Eif2s3y) revealed their comparable expression level in samples 
from TBR2+ IPCs and TBR2-cells (Fig. S2.1C). The data suggests that TBR2+ and TBR2- cell 
populations were derived from a similar number of female and male embryos. 
Next, we sought to identify genes with significant differences in expression level 
between the two cell populations and used these expression estimates to identify clusters. 
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Cuffdiff2 was used to identify 1119 enriched IPC genes (1050 protein-coding and 69 lncRNAs) 
and 1714 enriched non-IPC genes with significant differential expression between the cell types 
(p-value < 0.01 & |fold change| > 1.0, Fig. 2.1E/F). The IPC-enriched genes were annotated 
into different functional categories (Fig. 2.1G, Fig. S2.1D-E, Table S2, see Experimental 
Methods). The significance of such predominating gene clusters was analyzed and is discussed 
later.  
The reliability of our analyses was ensured by validating the expression pattern of the 
identified IPC-enriched genes in mouse developing cortex. In situ hybridization (ISH) for 392 
of such genes confirmed their restricted expression in SVZ in the E14.5 cortex, which is 
consistent with their RNA expression profiles (Table S3). To further validate the quality of our 
RNA-seq data, we performed immunohistochemical analysis of the E15.5 mouse cortex for 
ESCO2 as one of novel IPC factors. ESCO2 protein expression was mainly observed in the 
germinative zone of the developing cortex, especially the basal aspect (Fig. 2.1H). 
Quantification revealed that most of the cells expressing ESCO2 also expressed the IPC marker 
TBR2, but to a less extent in cells in the transition stage between RGC-IPC (PAX6+/TBR2+) 
and in RGCs (PAX6+) (Fig. 2.1I). 
Previous studies, which have characterized the transcription profiles of single cells 
isolated from the developing mouse cortex, have generated a repository of genes enriched in 
each of the murine cortical cell types (Kawaguchi et al., 2008; Li et al., 2020b; Loo et al., 2019; 
Telley et al., 2016). To identify novel IPC genes that might play essential roles in the 
development of this cell type, we compared the list of mouse IPC genes from these scRNA-seq 
experiments and from sorted TBR2+ IPCs (this study) and found that our list of IPC-enriched 
genes contains most of the previously identified IPC genes (Fig. S2.1E). Intriguingly, 961 out 
of the 1121 IPC enriched genes from this study (Fig. S2.1D) were not present in any of the gene 
lists of the above mentioned studies. GO analysis indicated that these novel IPCs encode for 
proteins belonging to different families of factors, such as chromatin/epigenetic factors, DNA-
, RNA-binding factors, and post-transcription/translation modification factors (Table S2, Fig. 
S2.1E). 
Together, the results demonstrate an efficient isolation of mouse TBR2+ IPCs, which 
allow adequate molecular profiling. 
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Figure 2.1 Cell Sorting and Gene Expression Profiling of Mouse TBR2+ IPCs 
(A) Micrograph showing the E16.5 mouse cortex immunostained with TBR2 antibody. Counterstaining was done 
with 4′,6-diamidino-2-phenylindole (DAPI). (B) An illustration of the experimental design used to sort out TBR2-
labled IPCs and subsequent nuclear analysis to compare the transcriptional profile of IPCs in mouse. (C) 
Representative images of pre- and post-sorted cell suspensions from mouse cortex stained with TBR2 antibody. 
 24  
 
Counterstaining was done with DAPI. (D) Representative plot showing sorting gates for TBR2+ and TBR2− cells 
from mouse and human cortex. (E and F) Volcano plot (E) and heatmap (F) showing the enrichment of IPC and 
non-IPC genes in corresponding sorted cell populations. (G) Pie chart showing proportions of the enrichment score 
of the top ten functional annotation clustering in IPCs. (H) Micrograph of immunohistochemical (IHC) staining 
showing the E15.5 wild-type mouse cortex at low and high magnification stained with ESCO2, TBR2, and PAX6 
antibodies. Cortical area with high magnification is indicated by a white box. Arrows point to TBR2+ IPCs co-
expressing ESCO2 but not PAX6. (I) Composite bar graph showing the quantitative proportion of ESCO2+ cells 
co-expressing PAX6 or TBR2 or both in germinal zone of the E15.5 mouse cortex. n = 6 experimental replicates. 
Scale bars, 100 μm (A) and 50 μm (C and H). 
 
2.3.2 Predominance of mitotic cell cycle and mitotic chromatid segregation-related gene 
signatures in IPCs 
Previous studies revealed that IPCs are transient cortical progenitors, which actively undergo 
mitotic cell divisions (Hevner, 2019). Consistent with these features of IPCs, many of the genes 
in the top GO pathways belong to cell cycle and cell division-related categories (Fig. 2.2A). 
Remarkably, our gene expression profiling revealed genes encoding for many cyclin and cyclin 
cofactors are highly expressed in IPCs (Fig. 2.2B/C, Table S4). Examination of these cell cycle 
regulation genes in subtypes of IPCs might offer a yardstick for distinguishing neurogenic IPCs 
from proliferative IPCs.  
During cell division, chromosomes need to be segregated and evenly distributed among 
daughter cells to ensure accurate passing of genetic information to the next generation. In 
addition to the alterations in mRNA levels for genes involved in cell cycle regulation, high 
expression of genes related to DNA replication, repair, and chromatid segregation were 
observed (Fig. 2.2A, Table S4). Particularly, expression of genes encoding for subunits of the 
chromosome segregation machinery is highly enriched in IPCs, e.g. Cohesin complex (Sgol1, 
Sgol2, Smc3, Rec8, Cdca5, and Wapal), Condensin complex (Ncapd2, Ncapd3, Ncapg, Ncaph, 
Smc2, and Smc4), Minichromosome maintenance complex (Mcm2, Mcm3, Mcm4, Mcm5, 
Mcm6, Mcm7, and Mms22l), and SMC5-SMC6 complex (Smc5, Smc6, Nsmce2, and Nsmce4a) 
(Fig.2.2D/E, Table S4). Single gene factors (e.g. Esco2, Spag5, Ncapg) involved in 
chromosome segregation were also identified in IPCs (Fig. 2.2D/E).  
The results shown here indicate that the expression of many cell cycle and chromatid 
segregation genes is associated with, and supportive for, the highly active cell division of IPCs. 
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Figure 2.2 Expression of Many Cell-Cycle and Chromatid-Segregation Genes Are Enriched in IPCs 
(A) Graphical representation of gene ontology analysis with terms related to cell cycle and segregation of 
chromatids. (B and D) List of the genes identified in IPCs that functionally fall under cell-cycle- and chromosome-
segregation-related processes, respectively. (C and E) Respective array of micrographs showing in situ 
hybridization of examples of the identified genes (highlighted red in B and D) with distinctive expression in the 
developing mouse cortical subventricular zone, and related to cell-cycle and chromosome-segregation events. 
Magnified cortical region is shown by a red box in (C). Scale bar, 100 μm. 
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2.3.3 Many IPC-enriched genes belong to signaling pathways 
Pathway enrichment analysis revealed that several brain-regulating signaling pathways are 
significantly enriched in IPC genes, including the P53-Caspase cascade, Hippo, Notch, FoxO, 
PI3K-Akt, Axon guidance, and Fanconi anemia signaling pathway (Fig. 2.3A). Corroborating 
the results from the transcriptomics analysis, we confirmed an enrichment of several genes 
belonging to these signaling pathways in SVZ (Fig. 2.3B–Q). The identified signaling pathways 
may play unique roles in the proliferation, differentiation and/or survival of IPCs during cortical 
development. 
Cell lineage tracing experiments with TBR2-CreER indicated that the majority of IPC 
derived clones (~66%) generate one daughter cell as neuron and another as apoptotic cell, 
indicating asymmetric cell death (Mihalas and Hevner, 2018). The observed remarkable 
abundance of apoptosis of IPC daughter cells is in accordance with previous findings of high 
level of cell death in the SVZ (Blaschke et al., 1996; Thomaidou et al., 1997). These outcomes 
are congruent with our GO analysis, which revealed that many genes belonging to the P53 
signaling cascade and caspase signaling pathway, which lead to apoptosis, are enriched in IPCs 
(Fig. 2.3B‒E, Table S5). Indeed, immunohistochemical analysis indicated a large proportion of 
CASP3+ cells immunoreactive with TBR2 in the developing mouse cortex at E16.5 (Fig. S2.2), 
corroborating the finding that more than half the progenies of IPCs undergo apoptotic cell death 
in the normally developing cortex (Mihalas and Hevner, 2018). 
Hippo signaling is necessary for cell fate and organ size determination (Zheng and Pan, 
2019). Emerging evidence shows the involvement of the Hippo signaling alone or cooperatively 
with other signaling pathways in brain development (Ouyang et al., 2020). As shown in our 
transcriptomic analysis, genes involved in the Hippo signaling pathway are prominently 
expressed in IPCs (Fig. 2.3F/G) and likely critical for the regulation of cortical size via control 
of IPC genesis (Kostic et al., 2019). Other signaling pathways such as the Delta‐Notch (Fig. 
2.3H/I), FoxO (Fig. 2.3J/K), PI3K-Akt (Fig. 2.3L/M), Axon guidance (Fig. 2.3N/O), and 
Fanconi anemia (Fig. 2.3P/Q) were also identified to be enriched in IPCs. These signaling 
pathways may play critical roles in the normal progression of brain morphogenesis via 
modulation of IPC biogenesis. 
Together, the enrichment of signaling pathway genes in the sorted IPCs is indicative of 
their necessity in sustaining the neuronal progenitor properties of IPCs in the SVZ niche and to 
permit their function in cortical morphogenesis. 
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Figure 2.3 IPC-Enriched Genes Encode for Variety of Signaling Pathway Factors 
(A) Graphical representation of the top-ranked signaling pathways that are prominent in IPCs. (B, D, F, H, J, L, 
N, and P) List of the genes identified in IPCs that are involved in the P53, Caspase, Hippo, Notch, FoxO, PI3K-
Akt, Axon guidance, and Fanconi anemia signaling pathways, respectively. (C, E, G, I, K, M, O, and Q) Respective 
array of micrographs showing in situ hybridization of examples of the identified signaling pathway-linked genes 
(highlighted red in the adjoining gene list) with distinctive expression in the developing mouse cortical 
subventricular zone. Magnified cortical region is shown by a red box in (C). Scale bar, 100 μm. 
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2.3.4 Identification of new IPC-specific transcription and epigenetic regulators 
Many of the genes identified in IPCs were found to participate in the regulation of transcription, 
chromatin remodeling, and other epigenetic processes (Fig. 2.4A). We first looked for 
epigenetic and chromatin regulators, which are highly expressed in IPCs. We found enrichment 
of epigenetic genes in the sorted IPCs: a total of 66 genes, 25 of which were validated by ISH 
(Fig. 2.4B/C, Table S6). Such epigenetic genes include Deacetylase genes, genes related to the 
PRC2 complex, and genes encoding for Methyltransferase domain-containing proteins. 
A set of IPC genes which encode for protein factors that form complexes to regulate 
chromatin dynamics was identified. In all, we found 52 such genes markedly expressed in IPCs, 
and with distinctive expression in the SVZ, at least for 24 of them (Fig. 2.4D/E, Table S6). The 
identified chromatin modification related-genes belong to the following classes of chromatin 
remodelers: SWI/SNF superfamily-type complex, and ISWI-type complex, NuRD/CHD 
complex (Table S6).  
Besides epigenetic and chromatin regulators, our data provided a context to examine the 
relative contribution of specific non-coding (nc)RNAs, and TFs, to IPC identity and/or 
regulation. We identified 69 known long non-coding (lnc)RNAs and 3 small nucleolar RNAs 
(sno) RNA genes, with significantly higher level of expression in TBR2+ IPCs compared with 
TBR2- cells (log2FC>1.0, p-value<0.01) (Fig. 2.4F/G, Table S6). Among these ncRNAs, ISH 
analysis confirmed the restricted expression of three lncRNAs (A930024E05Rik, 
5330426P16Rik, 9630028B13Rik, Fig. 2.4G) in SVZ of the developing cortex. 
We identified 104 IPC genes encoding TFs belonging to more than four protein families 
(Fig. 2.4H/I, Fig. S2.3, Table S6). C2H2 type zinc finger protein family was the most enriched 
protein family, with 47 up-regulated genes, followed by basic-helix-loop-helix (bHLH)/Myb, 
and homeobox protein families with 9 up-regulated genes each. The LIM TF family genes were 
also found in the purified IPCs (Fig. S2.3A–I). The genes encoding for TFs, which were found 
to exhibit a high expression in IPCs included many known key regulators of neurogenesis such 
as Eomes (Tbr2), Ngn1, Ngn2, NeuroD1, and Bag2, as well as many yet uncharacterized genes 
(e.g., Nhlh1, Csrp1, and Mybl2; Fig. 2.4H) that may prove to be novel regulators of cortical 
development. 
Next we determined which of the transcription factors interact physically or functionally 
using the STRING database. This revealed a highly interconnected network formed by IPC-
enriched TFs. Several TFs formed a network hub. Among them Cbfa2t2, Neurog2, Neurog1, 
Stat3, Neurod1, and Tcf3 appear to be in the center of the network as they interact with many 
other TFs (Fig. 2.4J). This raises the possibility that the components of this TF network are key 
determinants in IPC biogenesis. 
Taken together, our findings indicate major elements of the transcriptional and 
epigenetic machinery distinctively present in mouse IPCs. 
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Figure 2.4 Identification of Novel IPC-Specific Transcription Regulators 
(A) Graphical representation of the total number of newly identified genes and their categorization in IPCs that 
have the potential to regulate transcription. (B, D, F, and H) List of the genes identified in IPCs that are 
transcription regulators and can be grouped as epigenetic, chromatin, lncRNA, and transcription factors, 
respectively. (C, E, G, and I) Respective array of micrographs showing in situ hybridization of examples of the 
identified transcription regulation genes (highlighted red in the adjoining gene list) with distinctive expression in 
the developing mouse cortical subventricular zone. Magnified cortical region is shown by a red box in (C). Scale 
 30  
 
bar, 100 μm. (J) Protein-protein interaction network of the IPC-enriched transcription factors (TFs). The list of 
TFs were imported into the STRING database (http://string-db.org/), and the physical or functional interactions 
between the differentially expressed transcription factors were extracted using the default settings. The red and 
blue nodes represent IPC-enriched TFs with log2FC > 1.0 and 0.3 < log2FC < 1.0, respectively. The thin lines 
indicate low interaction score (<0.4) while the thick lines indicate medium or high interaction score (≥0.4). 
 
2.3.5 Gene expression profiling suggests mutations of IPC-enriched genes have 
implications for cortical neurodevelopmental disorders in human 
Recent single-cell transcriptomic analysis of the human developing cortex identified a large set 
of IPC genes (Fan et al., 2018; Li et al., 2018a; Nowakowski et al., 2017; Pollen et al., 2015; 
Zhong et al., 2018) and IPC lncRNAs (Liu et al., 2016). To further study the developmental 
and evolutionary origin of the transcriptional signature of IPC cells, we compared these 
published scRNA data for human developing cortex to those for mouse developing cortex 
(Kawaguchi et al., 2008; Li et al., 2020b; Loo et al., 2019; Telley et al., 2016) and to bulk RNA-
seq for mouse TBR2+ IPCs (this study, Fig. S2.4). The comparisons revealed not only 
remarkable match between the two species, but also highlighted an expanded gene expression 
program in human IPCs (Fig. S2.4).  
Mutations of the IPC-specific gene Tbr2/Eomes cause microcephaly and a wide range 
of cortical anomalies in both rodent (Arnold et al., 2008; Mihalas et al., 2016; Sessa et al., 2008) 
and human (Baala et al., 2007). In addition to congenital microcephaly, the affected individuals 
presented with dilatation of cerebral ventricles, agenesis of corpus callosum, polymicrogyria, 
and dysgenic cerebellum (Baala et al., 2007). The affected children also exhibited severe motor 
deficits, with hypotonia and intellectual disability (Baala et al., 2007). 
To identify a potential involvement of these common IPC genes (Fig. S2.4B), which 
were found both in developing cortices from mouse (this study) and human (Fan et al., 2018; 
Li et al., 2018a; Nowakowski et al., 2017; Pollen et al., 2015; Zhong et al., 2018), in human 
diseases, we performed systematically Human Phenotype Ontology (HPO) analysis (Robinson 
et al., 2008) (Fig. 2.5A). Mutations of many IPC genes were found to be associated with 
intellectual-disability phenotype, thus supporting the idea that the perturbation of many 
biological pathways in IPCs can undermine cognitive development. In order to determine 
possible convergence of the various molecular pathways on intermediate phenotypes within the 
scope of intellectual disability, including brain structure malformations, we looked for 
correlated phenotypes among the 134 intellectual disability genes (Fig. 2.5B/C, Table. S7). We 
identified two major associated phenotypes: (1) microcephaly, and (2) corpus callosum 
agenesis (Fig. 2.5D–G, Table. S7). This observation supports the findings that IPCs generate 
most of the cortical projection neurons, especially, upper layer/callosal neurons, which are 
necessary for appropriate cortical size and proper establishment of cortical neuron connections 
across the corpus callosum. 
In summary, many gene sets encode for components of the transcriptional, chromatin, 
and signaling machineries in mouse IPCs, with known or putative regulatory function in cell 
division, proliferation, differentiation and survival (Fig. 2.5H). Our data supports the possibility 
that major elements of the mouse IPC transcriptome may be conserved in human and play 
important roles in cortical development, with their mutations plausibly underlying cortical 
malformations and dysfunction in both species. 
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Figure 2.5 Mutation of IPC Genes May Underlie Human Cortical Malformation and Intellectual Disability 
(A) Graphical representation of human phenotype ontology for TBR2+ IPCs genes showing the top ten phenotypes 
and others that follow in ranking. (B, D, and F) List of the genes identified in IPCs with phenotypic implications 
for intellectual disabilities, microcephaly, and corpus callosum agenesis, respectively. (C, E, and G) Respective 
array of micrographs showing in situ hybridization of examples of genes (highlighted red in the adjoining gene 
list) with distinctive expression in the developing mouse cortical subventricular zone, and whose dysfunction can 
lead to abnormal cortical structure and function. CC, corpus callosum. Magnified cortical region is shown by a red 
box in (C). Scale bar, 100 μm. (H) Schema showing examples of regulatory factors involved in transcription 
regulation, signaling pathways in progenitor cells, and those involved in the cell cycle and chromosome 
segregation that drive cellular processes such as proliferation, differentiation, and apoptosis. 
 
2.3.6 Uncovering ESCO2 as a novel IPC-enriched gene essential for SVZ formation and 
cortical neurogenesis 
Among the novel IPC genes, ESCO2 is in top 100 of IPC-most enriched genes (Table S1). GO 
analysis also revealed that ESCO2 belongs to top gene categories, including cell cycles, 
chromatin segregation, transcription regulation, DNA replication and chromatin organization 
pathways (Table. S2, S4, S5, S6, S7). Mechanistically, ESCO2 and its orthologous ESCO1, 
encoding for cohesin acetyltransferases, are essential for establishing cohesion between sister 
chromatids by acetylating the SMC3 subunit of the cohesion ring (Nishiyama et al., 2010; Rolef 
Ben-Shahar et al., 2008; Unal et al., 2008). In contrast to a highly-enriched expression of 
ESCO1 in RGCs in VZ (Fig. S2.5A‒ C), expression of ESCO2 is mostly restricted to IPCs in 
SVZ (Fig. 2.1H/I, Fig. S2.5D‒F). This raises a possibility that ESCO1 and ESCO2 play an 
important role in biogenesis of RGCs and IPCs, respectively. 
To understand the role of selected IPC-specific genes in corticogenesis, we 
characterized functions of ESCO2 in IPC development. Previous studies has shown that ESCO2 
has a critical role in the formation of cortical layers (Whelan et al., 2012b) and its de novo 
mutations cause primary microcephaly in Roberts-syndrome patients (Vega et al., 2005), 
suggesting that it might have important, yet undiscovered, roles in the specification and viability 
of IPCs, and in orchestrating cortical neurogenesis. 
To find out the functional significance of ESCO2 during cortical development, we 
ablated ESCO2 gene in the early developing mouse cortex using an Emx1-Cre driver (Gorski 
et al., 2002; Whelan et al., 2012b). Similar to the gradient expression pattern of Emx1, Emx1-
Cer activity is found first in the medial-dorsal cortex (MCX, DCX) at E10.5 and extends to the 
lateral cortex (LCX) from E12.5 onward (Gorski et al., 2002). Because the Emx1-Cre is active 
differently in different cortical areas, we first examined the cortical phenotype of ESCO2cKO 
mutants in MCX and DCX areas (Fig. 2.6A). At E12.5, the ESCO2-ablated presumptive cortex 
displayed a notable reduction in thickness or size compared with control (Fig. 2.6A). A closer 
examination revealed a reduction in the population of PAX6+ RGCs in the ESCO2cKO cortex 
compared with control (Fig. 2.6A/B). Strikingly, the pool of the TBR2+ IPCs is largely lost in 
MCX and DCX areas of mutants (Fig. 2.6A/B). As indicated by immunostaining for the 
apoptotic cell marker CASP3, there was overt cell death in the E12.5 ESCO2cKO mutant cortex 
in the examined cortical areas (Fig. 2.6C). 
In accordance with the Emx1-Cre activity, the cortical phenotype of ESCO2cKO 
mutants appeared mild in LCX than in MCX and DCX (Fig. 2.6A‒C). Particularly, the 
population of PAX6+ RGCs and TBR2+ IPCs were fairly preserved in the cKO LCX (Fig. 
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2.6A/B). In addition, the CASP3+ apoptotic cells were found mostly in the basal side of mutant 
LCX (Fig. 2.6C). Of note, further differential analysis indicated that majority of the cells 
undergoing apoptosis in the ESCO2cKO LCX were TBR2+ IPCs (Fig. 2.6C‒E, empty arrows) 
and cells in transition stage between RGCs and IPCs (i.e. PAX6+, TBR2+) (Fig. 2.6C‒E , filled 
arrows), albeit other cortical cell types like PAX6+ RGCs and NEUN+ postmitotic neurons 
also registered apoptotic activity, but to a lesser extent (Fig. 2.6D/E). 
Given the reduction in the progenitor pool and death of differentiated neurons, we found 
drastic decrease in the number of NEUN+ or HUCD+ neurons in the presumptive ESCO2cKO 
cortex compared with control (Fig. S2.6). Our observations are consistent with previous studies, 
which reported that cortical layers are not formed as a result of ESCO2 abolishment (Whelan 
et al., 2012b). 
Together, this part of our investigation shows that ESCO2 is expressed in a subset of 
PAX6+ RGCs and TBR2+ IPCs in the developing cortex. The expression of ESCO2 is required 
for the viability of these cell populations and their progenies to afford proper cortical 
histogenesis. 
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Figure 2.6 Lack of ESCO2 Causes Apoptosis of Cortical Progenitors Leading to Disturbance of Cortical 
Development 
(A) Micrographs showing low and high magnification of the E12.5 control (wild-type) and Esco2 cKO cortex 
immunostained for PAX6 and TBR2. The medial (MCX), dorsal (DCX), and lateral (LCX) aspects of the cortex 
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are indicated. Counterstaining was done with DAPI. (B) Bar graph showing quantification of PAX6+ and TBR2+ 
cells in the E12.5 control and Esco2 cKO dorsal cortical area marked with a white box in (A). (C) Micrographs 
showing low and high magnification of the E12.5 control and Esco2 cKO cortex immunostained for PAX6, TBR2, 
and the apoptosis marker CASP3. Counterstaining was done with DAPI. The medial (MCX), dorsal (DCX), and 
lateral (LCX) aspects of the cortex are indicated. The basal and apical sides of the cortex are shown. Filled arrows 
point to PAX6+/TBR2+ cells, which are in transition stage between RGCs and IPCs, undergoing apoptosis 
(CASP3+), whereas empty arrows point to apoptotic (CASP3+) TBR2+ IPCs. (D and E) Bar graph (D) showing 
quantification of the number of PAX6+, TBR2+, PAX6/TBR2+, or NEUN+ cells undergoing apoptosis, and 
composite bar graph (E) showing the quantitative proportion of CASP3+ cells co-expressing PAX6 or TBR2 or 
NEUN in the lateral cortex (marked with white box in C). Error bars are SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. 
Experimental replicates (n) = 4 (B) and 6 (D and E). Scale bars, 50 μm (lower panels in A and C) and 200 μm 
(upper panels in A and C). 
 
2.3.7 ESCO2 is required for maintenance of the IPC population in developing cortex 
Because the loss of ESCO2 in early cortical progenitors in transgenic ESCO2cKO mutants 
caused massive apoptosis and cortical dysgenesis, we were limited in examining the role of 
ESCO2 at later stages of cortical development. Alternatively, in utero electroporation (IUE) 
technique was employed to acutely delete ESCO2 from individual RGCs in the developing 
mouse cortex. The prominent expression of ESCO2 in IPCs and cells in the transition between 
RGCs and IPCs as well as the massive loss of these cell types following ablation of ESCO2 in 
the early developing cortex in ESCO2cKO embryos, prompted us to investigate whether 
ESCO2 influences the cell viability and generation of TBR2+ IPCs from RGCs in late 
corticogenesis. 
The brains of ESCO2fl/fl embryos at E15.5 were electroporated either with pCIG2-Cre-
ires-GFP (Cre-GFP) or control pCIG2-ires-GFP (GFP) plasmids. The cortices were harvested 
30 hours post-electroporation (i.e., at E16.5) and processed for immunohistological analyses 
(Fig. 2.7A/C). At mid-gestation, RGCs undergo only one division in less than 24 hours to 
produce daughter cells mainly IPCs in the developing mouse cortex (Noctor et al., 2004). To 
study the viability of AP daughter cells and the generation of IPCs from RGCs after deletion of 
ESCO2 in the VZ, we performed triple immunostaining for GFP/PAX6/CASP3 and for 
GFP/TBR2/CASP3 at E16.5 (Fig. 2.7A/C). 
The electroporated (eGFP+) cells mainly occupied the VZ and the basal half of the 
cortical wall (i.e., SVZ and IZ). In contrast to almost no CASP3+ cells found in control (GFP) 
plasmid-injected cortex, many CASP3+ apoptotic cells were seen in Cre-electroporated cortex 
as expected (Fig. 2.7A/C). In the Cre-injected cortex, majority of the GFP+/CASP3+ cells were 
found to be either negative (~80.0±11.4%) or low (~17.6±5.4%) for PAX6 expression (Fig. 
2.7A/B). On the other hand, the number of GFP+/CASP3+ cells expressing TBR2 was much 
higher (78.0±9.7%) than those without TBR2 expression (Fig. 2.7C/D). The findings further 
support the idea that expression of ESCO2 is required for TBR2+ IPC viability and those of 
committed RGCs (with low PAX6 expression) to generate IPCs in both early and late cortical 
development. 
Interestingly, there was no significant difference between the GFP- and Cre-GFP-
electroporated cortex in terms of the number of transfected cells (GFP+) expressing PAX6 or 
TBR2 (Fig. 2.7E). Thus, ESCO2 is dispensable for the differentiation of RGCs, which are low 
in ESCO2 expression (Fig. 2.7F, Fig. S2.5), into IPCs. It implies that following the acute 
deletion of ESCO2, IPC as progenies of PAX6-expressing RGCs are likely normally formed 
 36  
 
but fail to survive. It is also conceivable that NEUN+ or HUCD+ neurons that manage to 
differentiate from the ESCO2-deficient cortical neural progenitors, especially IPCs, are 
unhealthy and subsequently die via apoptosis (Fig. 2.7F, Fig. S2.6). 
Taking our data together, we show that ESCO2 expression is essential for the 
maintenance of IPCs and proper neurogenesis during cortical development. 
 
 
Figure 2.7 Expression of ESCO2 Is Important for Maintenance but Not Generation of IPCs 
(A and C) Micrographs at low and high magnification showing GFP, CASP3, and PAX6 (A) or TBR2 (C) 
immunostaining in the E16.5 Esco2fl/fl mouse cortex electroporated with a GFP-only plasmid as control and GFP-
Cre plasmid to delete Esco2 in the transfected cells. (B and D) Composite bar graphs showing quantitative analysis 
of the proportion of GFP and CASP3 positive cells with either no/low/high PAX6 expression (B) or with/without 
TBR2 expression (D). (E) Bar graphs showing no significant difference between the total number of cells co-
expressing GFP and PAX6 or GFP and TBR2 when the control (GFP-only) and knockout (GFP-Cre) cortices are 
compared. Error bars are SEM. (F) Schema illustrating the expression of PAX6, TBR2, NEUN, and ESCO2 during 
differentiation of radial glial progenitors to intermediate progenitors and neurons. The loss of ESCO2 in 
Esco2cKO_Emx1-Cre seems to cause apoptosis in the late radial glial progenitors (PAX6+/TBR2+), intermediate 
progenitors (TBR2+), and neurons (NEUN). NS, not significant. Experimental replicates (n) = 6 (B, D, E). Scale 
bar, 50 μm. 
 
2.4 Discussion 
Transcriptome analyses of molecularly sorted cells can enrich the identification of celltype-
specific factors, which can help us understand the molecular landscape in cell lineages. In this 
study, we report the molecular characterization of the evolutionarily and clinically important 
population of IPCs in the developing mouse cortex. We identified distinct sets of largely 
uncharacterized genes that exhibit enriched expression in IPCs among other cell types in the 
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developing cortex. The set of genes were found to belong to transcription regulators, chromatin 
and epigenetic factors, signaling factors, and chromosome segregation (cell cycle) regulators. 
These genes encode critically important molecules for proper proliferation, differentiation and 
maintenance of IPCs. Even though our understanding of the contribution of IPCs in cortical 
development has improved, several key questions remain enigmatic (Hevner, 2019). Our study 
represents the first comprehensive characterization of the molecular signature of IPCs in 
developing mouse cortex. The findings provide hints for future investigation to resolve the 
many unanswered questions. 
Previous studies indicate that more than half of the IPC daughter cells undergo apoptosis 
during corticogenesis (Hevner, 2019; Mihalas and Hevner, 2018). The relevance of this 
observed phenomenon is undetermined, however, it might associate with the regulation of the 
net neurogenic output, genome quality, neuronal subtype proportions during cortical 
development and cortical evolution (Haydar et al., 1999; Hevner, 2019). The observed high 
abundance of apoptotic cells among IP daughter cells harmonizes with previous reports 
documenting marked cell death in the SVZ and IZ of embryonic rodent cortex (Blaschke et al., 
1996; Thomaidou et al., 1997). In the same line of evidence, our GO analysis revealed that 
genes belonging to the caspase cascade in apoptosis are enriched in IPCs. Remarkably, 
disruption of the caspase cascade leads to decreased programmed cell death resulting in 
neuronal supernumerary, which likely accounts for the expansion and exencephaly of the 
forebrain, cerebral gyrification (Kuida et al., 1998; Kuida et al., 1996). Conversely, 
dysregulation of chromosomal segregation can cause an increase in neural progenitor cell death 
leading to loss of neurons as exemplified in our ESCO2 case study. Thus, the proper 
coordination of the various aspects of the apoptotic signaling pathway, especially during 
embryonic neurogenesis, is essential for the determination of normal cortical size and form. 
Given the critical contribution of apoptosis to correct progression of cortical morphogenesis, it 
would be of great interest for future investigations to elucidate the precise mechanisms that 
trigger apoptotic cell death of neural cells during cortical development. 
Notably, our validation investigations revealed that lack of ESCO2, one of the identified 
IPC-enriched genes, results in striking loss of IPC population, leading to the failure of proper 
formation of the cortex. By using different model systems such as yeast, primary mouse 
embryonic fibroblasts and human cells (HeLa and 293T human embryonic kidney cells), 
previous studies reported that ESCO2 is crucial for sister chromatid tethering (Hou and Zou, 
2005; Terret et al., 2009; Vega et al., 2005; Whelan et al., 2012a; Whelan et al., 2012b). It is 
known to do so via its catalytic function in cohesin acetylation that ensures proper cohesion 
between sister chromatids. Indeed, dysfunction of ESCO2 has been shown to result in loss of 
cohesion at heterochromatic regions of centromeres, leading to defective localization of cohesin 
on chromosomes and apoptosis (Hou and Zou, 2005; Terret et al., 2009; Vega et al., 2005). In 
developing mouse cortex, a highly-enriched expression of ESCO1 and ESCO2 was found in 
RGCs in VZ and in IPCs in SVZ, respectively. This suggests a possibility that the cohesion 
acetyltransferases ESCO1 and ESCO2 are key cell viability factors, which act by maintaining 
the appropriate cohesion in pericentric heterochromatin in RGC and IPC populations. Indeed, 
our findings indicate that ESCO2 is indispensable for IPC maintenance and demonstrate the 
identification of a central genetic determinant of IPC biogenesis in the developing mouse 
cortex. 
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In conclusion, our transcriptome data provide a crucial resource for further 
investigations aimed at understanding how IPC-related genetic factors contribute to cortical 
development and their implication for neurological disorders. Moreover, because IPCs are 
believed to be responsible for a large portion of mammalian corticogenesis, and the size of the 
IPC-laden SVZ correlates with brain phylogeny, future studies can look into the role of the 
identified IPC genes in cortical evolution. 
 
2.5 Experimental procedures 
 
2.5.1 TBR2+ nuclei sorting protocol for transcriptomic data generation from embryonic 
mouse brain 
Cells expressing TBR2 in the E16.5 mouse cortex were isolated by FACS and profiled using 
RNA sequencing. The detailed protocol is reported in Sakib et al. (2021). The experiment was 
carried out using three biological replicates 
 
2.5.2 RNA sequencing and bioinformatics analysis 
Sorted nuclei were collected into NSB coated falcon tubes, pelleted with brief centrifugation 
and the RNA was isolated using Trizol LS (Invitrogen) protocol along with aqueous phase 
cleanup using Zymo RNA clean & concentrator-5 kit. RNAseq libraries were prepared using 
Takara SMART-Seq v4 Ultra Low Input RNA kit using 1ng of RNA according to the 
manufacturer’s protocol. Base calling, fastq conversion, quality control, and read alignments 
were all performed as outlined previously (Narayanan et al., 2015; Nguyen et al., 2018). Reads 
were aligned to mouse genome mm10 and counted using FeaturesCount 
(http://bioinf.wehi.edu.au/featureCounts/). Further descriptions of informatics analyses are 
provided in supplemental experimental procedures. 
 
2.5.6 Transgenic mice and in utero electroporation (IUE) 
Floxed ESCO2 (Whelan et al., 2012b) and Emx1-Cre (Gorski et al., 2002) mice were 
maintained in a C57BL6/J background. Animals were handled according to the German Animal 
Protection Law. In utero electroporation was performed as described previously (Tuoc et al., 
2013; Tuoc and Stoykova, 2008). 
 
2.5.7 Plasmids and antibodies 
A list of plasmids and antibodies with detailed descriptions is provided in the supplemental 
experimental procedures. 
 
2.5.8 Immunohistochemistry (IHC) and in situ hybridization (ISH) validation 
IHC and ISH were performed as previously described (Bachmann et al., 2016; Tuoc et al., 2013; 
Visel et al., 2004). Briefly, sections for IHC were incubated overnight with primary antibody 
at 4 °C after blocking with normal sera of the appropriate species. Primary antibodies were 
detected with a fluorescent secondary antibody (Alexa Fluor, 1:400; Invitrogen). Sections were 
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later counterstained with Vectashield mounting medium containing DAPI (Vector laboratories) 
to label nuclei.  
A detailed ISH protocol with different conditions was described in our previous study 
(Visel et al., 2004) and can be found in our online digital atlas (https://gp3.mpg.de). The 
template sequence and ISH condition are described in webpage for each gene. 
 
2.5.9 Imaging, quantification, statistical analysis and data availability 
Micrographs were obtained by confocal fluorescence microscopy (TCS SP5, Leica) and 
analyzed using an Axio Imager M2 (Zeiss) with a Neurolucida system. Images were processed 
further using Adobe Photoshop. The statistical quantification was carried out as average from 
at least three biological replicate. Detailed statistical analyses and description for histological 
experiments are presented in Table S8. The in situ expression of all the identified IPC genes are 
freely available online (https://gp3.mpg.de) in an interactive database. 
 
2.6 Accession numbers 
All RNA-seq data have been deposited in the Gene Expression Omnibus under accession 
number GEO: GSE168298. 
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2.10 Supplemental figures 
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Figure S2.1 (related to Figure 2.1). RNA-seq analysis of mouse TBR2+ IPCs and TBR2-cells. 
(A) Cluster dendrogram analysis  of RNA-seq for TBR2+ and TBR2-sorted cell samples. (B) Heatmap showing 
the top 20 genes with high expression (enriched/upregulated) in TBR2+ IPCs and low expression in TBR2-cells. 
(C) Bar graph showing expression of selected IPC (in green), non-IPC (in blue) and gender-associated 
housekeeping genes (in red) in IPCs (TBR2+) and non IPCs (TBR2-) in the E16.5 mouse cortex. (D) An indication 
of the increased number of IPC-enriched genes identified in our study compared with previous studies performed 
at the IP single cell level. (E) Bar graph showing the molecular pathway analysis in TBR2+ IPCs and the number 
of genes belonging to each category of pathway. 
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Figure S2.2 (related to Figure 2.3). TBR2+ IPCs in mouse display prominent apoptotic activity. 
(A) Immunohistochemical micrographs showing an overview of E16.5 mouse cortex and highly magnified 
germinal zone stained with TBR2 and CASP3 antibodies. The zoomed area is indicated with white inserted box. 
Filled arrows point to TBR2+ IPCs undergoing apoptosis whereas empty arrow indicates apoptotic activity in a 
TBR2-cell. Counterstaining was done with DAPI. (B) Bar graph showing the proportion of TBR2+ and TBR2-
cells undergoing apoptosis. Experimental replicates (n) = 6 (B). Scale bar = 100 μm. 
 
Figure S2.3 (related to Figure 2.4). Enrichment of transcription factor genes in TBR2+ IPCs. 
(A) Bar graph showing the number of genes in IPCs under the indicated classes of transcription factor. (B, D, F, 
H) Categories of transcription factors with corresponding list of newly identified IPC-enriched genes. (C, E, G, I) 
Respective micrographs showing in situ hybridization of examples of the identified transcription factor genes 
(highlighted red in the adjoining gene list) with expression endowment in the developing mouse cortical 
subventricular zone. Magnified cortical region is shown with red box in (C). Scale bar = 100 μm. 
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Figure S2.4 (related to Figure 2.5). Many human bIP genes are upregulated in mouse TBR2+ IPCs while 
others are downregulated or absent. 
(A, B) Overlap between the number of human IPC genes from scRNA-seq analysis of the human developing cortex 
(Fan et al., 2018; Li et al., 2018a; Nowakowski et al., 2017; Pollen et al., 2015; Zhong et al., 2018) and number of 
mouse IPC genes, which was recently identified by scRNA-seqanalysis (Kawaguchi et al., 2008; Li et al., 2020b; 
Loo et al., 2019; Telley et al., 2016) (A), and by bulk RNA-seq (B, this study). (C) Bar graph showing both 
upregulated (enriched) and downregulated human bIP genes in TBR2+ IPCs compared with TBR2- cells in mouse 
cortex. (D) In situ hybridization micrographs showing the E14.5 mouse cortex riboprobed for the indicated human 
bIP genes. Magnified cortical region is shown with red box. Scale bar = 100 μm. 




Figure S2.5 (related to Figure 2.6). Expression of ESCO1 and ESCO2 in the developing mouse cortex. 
(A‒F) Expression of ESCO1 (A‒C) and ESCO2 (D‒F) were evaluated by RNA-seq with TBR2+ and TBR2- 
samples (A, D), single-cell (sc)RNA-seq (B, E), and ISH (C, F). (A, D) Bar graph indicating significant differential 
expression of ESCO1 (A) and ESCO2 (D) in TBR2+ IPCs compared with TBR2- cells in RNA-seq analysis. (B, 
E) Expression of Esco1 (B) Esco2 (E) based on a published single-cell scRNA-seq dataset of the developing mouse 
cortex (Telley et al., 2016). The graph-plots were generated using the Seurat package of R (Macosko et al., 2015) 
(http://genebrowser.unige.ch/science2016/). (C, F) Micrograph of in situ hybridization (ISH) staining showing 
prominence of Esco1 (C) and Esco2 (F) expression in VZ and SVZ of E14.5 mouse cortex, respectively. Magnified 
cortical region is shown with red box. Note that in contrast to a highly-enriched expression of Esco1 in RGCs in 
VZ, expression of Esco2 is mostly restricted in IPCs in SVZ. Abbreviations: RGC (Radial glial progenitor cell), 
IPC (Intermediate progenitor cell). Scale bar = 100 μm. 
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Figure S2.6 (related to Figure 2.7). Deletion of ESCO2 in developing cortex causes depletion of post-mitotic 
neurons via apoptosis. 
(A, C) Immunohistochemical micrographs showing staining of the E12.5 mouse cortex with the antibodies HUCD 
and NEUN (pan-neuronal markers), and CASP3 to mark post-mitotic neurons undergoing apoptotic cell death. (B, 
D) Bar charts showing quantification of the number of HUCD+ and NEUN+ cells in the lateral aspect of the E12.5 
cortex (marked with white box). The medial (MCX), dorsal (DCX), and lateral (LCX) cortical areas are indicated. 
*** p-value < 0.001, Experimental replicates (n) = 4 (B, D). Scale bar = 200 μm (A), 50 μm (C, lower panel). 
 
2.11 Supplemental tables 
Supplemental tables S1-8 can be found online at https://doi.org/10.1016/j.stemcr.2021.03.008. 
 
2.12 Supplemental experimental procedures 
 
2.12.1 Plasmids 
Plasmids used in this study: CAG-GFP-IRES-CRE (Zhao et al., 2006) from Addgene. 
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2.12.2 Antibodies 
The following polyclonal (pAb) and monoclonal (mAb) primary antibodies used in this study 
were obtained from the indicated commercial sources: CASP3 rabbit pAb (1:100; Cell 
Signaling), ESCO2 (Whelan et al., 2012), GFP chick pAb (1:400; Abcam), HUCD mouse mAb 
(1:20; Invitrogen), NEUN mouse mAb (1:200, Chemicon), PAX6 mouse mAb (1:100; 
Developmental Studies Hybridoma Bank), PAX6 rabbit pAb (1:200; Covance), TBR2 rabbit 
pAb (1:200; Abcam), TBR2 rat 923 mAb (1:200; eBioscience). 
Secondary antibodies used were Alexa 488-, Alexa 568-, Alexa 594- and Alexa 647- conjugated 
IgG (various species, 1:400; Molecular Probes). 
 
2.12.3 Functional enrichment analysis of IPC genes 
The lists of IPC genes (p-Value<0.01, log2FoldChange>1.0) were uploaded to the DAVID 
functional annotation tool (https://david.ncifcrf.gov/). Then, representative enriched biological 
functional terms were manually selected. To perform the Gene Set Enrichment Analysis 
(GSEA) analysis, the list of upregulated genes was uploaded to GSEA. Using FDR q-
value<0.05 as a cut-off generated the enriched biological and cellular component terms. The 
Fisher’s exact test was applied to identify the terms showing a statistically significant difference 
for the upregulated genes. 
 
2.12.4 Identification of IPC-enriched lnRNAs 
The lists of IPC genes (p-Value<0.01, log2FoldChange>1.0) were uploaded to the MGI gene 
nomenclature analysis tool (http://www.informatics.jax.org/batch). List of lnRNAs protein-
encoding genes was extracted from each other. 
 
2.12.5 Protein-protein interaction network 
The combined list of IPC-enriched genes encoding for TFs (chromatin remodelling and 
epigenetic factors, Fig. 2.4J) was uploaded to the STRING database (http://stringdb.org/). The 
protein-protein interactions from STRING were visualized by Cytoscape 
(https://cytoscape.org/; version: 3.3.0). 
 
2.13 Supplemental discussion 
 
2.13.1 Prominence of cell cycle-related factors in IPCs 
Further unanswered questions that need to be addressed to increase our understanding of ICP 
cell biology include (1) the reasons behind shorter S-phase and longer G1-phase, and total 
length of cell cycle in IPCs than in RGCs, and (2) what factors drive the proliferation of some 
IPCs in cell cycle?. In developing cortex, the length of G1 is increased in neurogenic progenitor 
cells compared with proliferative progenitors (Caviness et al., 2003; Dehay and Kennedy, 2007; 
Lukaszewicz et al., 2005; Salomoni and Calegari, 2010). As such, basal progenitors, including 
IPCs, are known to display a more extended G1 phase than RGCs (Calegari et al., 2005; 
Salomoni and Calegari, 2010). The increased G1 phase may support the more differentiative 
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capacity of IPCs compared with RGCs, thus likely promoting IPC fate (Dehay and Kennedy, 
2007; Lange et al., 2009). Indeed, functional manipulation of G1 length was shown to have 
effects that either support (i) IPC genesis leading to neurogenic division and premature 
neurogenesis (Calegari et al., 2005) or (ii) increased proliferative divisions, resulting in 
progenitor pool expansion, which manifests in cortical layer phenotypes later in development 
(Lange et al., 2009; Pilaz et al., 2009). Of note, we found a high expression of genes encoding 
for Cdks (Cdk2, Cdk4) with their regulator protein (Ccnd1, Ccnd2, Ccne1, Ccne2), which drive 
the G1 phase of cycling IPCs. Hence, it is worth to examine the proliferation capacity of IPCs, 
in which the expression of these G1-phase factors is specifically manipulated. 
 
2.13.2 Identification of new IPC-specific transcription factors 
An intriguing molecular difference between the TBR2+ IPCs and the TBR2- cells in the 
developing mouse cortex is the differential expression of genes, which encode for different TF 
families (Table S5). 
The zinc finger TFs form the largest protein family, having a wide range of molecular 
functions, and are involved in the development and differentiation of several cell lineages 
(Cassandri et al., 2017). Expression of many genes encoding for this TF family is enriched in 
IPCs. The role of the zinc finger proteins identified in this study in neurogenesis are largely 
unknown, except for that reported for the function of Uhrf1 in adult neurogenesis (Blanchart et 
al., 2018; Murao et al., 2019). 
The second largest family of TFs is the bHLH TFs, which play key roles in various 
developmental processes in organisms from yeast to humans (Jones, 2004). Class I bHLH 
proteins are ubiquitously expressed, whereas class II bHLH proteins are tissue-specific. The 
nervous system-specific bHLH factors can further be classified into proneural and neural 
differentiation genes (Dennis et al., 2019). Two closely-related nescient helix loop helix 1 
(Nhlh1/bHLHa35) and 2 (Nhlh2/bHLHa34) genes belong to the neural differentiation 
bHLH/Nscl subfamily genes (Dennis et al., 2019). In chicken, misexpression of Nhlh1 leads to 
an abnormal brain structure with an underdeveloped cerebellum and a larger tectum caused by 
changes in cell proliferation (Li et al., 1999). Nhlh1-deficient mice exhibit a predisposition to 
arrhythmia leading to an early death due to autonomic nervous system dysfunction (Cogliati et 
al., 2002). The phenotype was more severe when Nhlh1-knockout mice were also heterozygous 
for Nhlh2. The specific and high expression of Nhlh1 and Nhlh2 in IPCs (Table. S5) suggests 
that the two factors act together to control the IPC differentiation. Expression of other bHLH 
TFs, including Hes6/bHLHb41, Tcf3/bHLHb21, Tcf12/bHLHb20, Hey1/bHLHb31, and Ebf2, 
Srebf1/bHLHd1 were found to be enriched in IPCs. Among them, Hes6, Tcf3, Tcf12, Hey1 and 
Ebf2 were reported to be involved in neural development (Chuang et al., 2011; Gribble et al., 
2009; Methot et al., 2013; Nam et al., 2016; Sakamoto et al., 2003; Uittenbogaard and 
Chiaramello, 2002; Yang et al., 2015). For Srebf1, no studies have yet been published on its 
role in neural development, albeit associations with Schizophrenia and Parkinson’s disease 
have been reported, making a future investigation into its role in brain development even more 
interesting (Le Hellard et al., 2010; Lou et al., 2019; Yang et al., 2016). 
The homeobox TFs were also found to be highly expressed in IPCs. Homeobox genes 
are important for the embryonic development of diverse animals, and are often comparatively 
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analyzed to investigate evolution of animal development (Holland et al., 2007). Our 
investigation of genes enriched in IPC revealed three transcription factors that belong to the 
homeobox gene family. For two of the homeobox genes enriched in IPC, Meis homeobox 2 
(Meis2) and POU domain, class 4, transcription factor 1 (Pou4f1, also called Brn3a), a role for 
neural development has already been described. MEIS2 has been described as a regulator of 
dorsal midbrain development interacting with the paired-box transcription factors PAX3 and 
PAX7 (Agoston et al., 2012). In humans, MEIS2 mutations can cause intellectual disability 
(Douglas et al., 2018; Giliberti et al., 2019; Louw et al., 2015). In the developing nervous 
system, Pou4f1 was shown to be essential for the generation of dorsal root ganglia sensory 
neurons and the regulation of sensory afferent projections (Zou et al., 2012). The other 
homeobox gene is the one cut domain family member 2 (Onecut2), which is well known as a 
master regulator in cancer (Lu et al., 2018; Rotinen et al., 2018). Function of ONECUT2 in 
brain development has not yet been described, however, Onecut2 overexpression was shown to 
induce a neuron-like morphology and neuronal gene expression in fibroblasts making its role 
in neural development plausible (van der Raadt et al., 2019). 
Another group of TF genes found to be enriched in IPC lineage is the myeloblastosis 
oncogene-like (Myb-like) transcription factor. The transcription factor MYBL1 (also called A-
MYB) is known as a master regulator of meiosis (Bolcun-Filas et al., 2011), and in mice, it 
plays a vital role in spermatogenesis and mammary gland development (Toscani et al., 1997). 
Although Mybl1 expression in neuronal progenitor cells has already been described (Trauth et 
al., 1994), its specific role in brain development is far from clear. Similarly, another Myb-like 
transcription factor, named MYBL2 or B-MYB was found to be enriched in IPC. MYBL2 is 
involved in cell proliferation and survival, however, these roles have been investigated mainly 
in cancer research and a possible function in neurogenesis has not been determined so far (Chen 
and Chen, 2018; Musa et al., 2017). 
Altogether, our investigation of genes specific to IPCs revealed the expression of many 
transcription factors that were previously not known and, thus, are putative genetic 
determinants of this cohort of neuronal progenitor cell type. Understanding the function of these 
IPC-enriched TFs would not only shed light on the mechanisms of cortical development, but 
also provide suggestions for ways to generate this cell type by direct reprograming from other 
cell linages. 
 
2.13.3 Mutation of IPC-enriched genes is implicated in human neurodevelopmental 
disorders and neuropsychiatric diseases 
The single-cell transcriptomic analysis of human developing cortex has identified a set of IPC 
genes (Fan et al., 2018; Li et al., 2018a; Nowakowski et al., 2017; Pollen et al., 2015; Zhong et 
al., 2018). As part of further investigations, we compared in silico expression of such human 
IPC genes with our identified mouse IPC transcriptome to identify the developmental and 
evolutionary origin of the transcriptional signature of IPC cells. Our data suggest the existence 
of both conserved and non-conserved transcriptional signatures of IPCs in mammalian 
evolution. Consistent with this line of evidence, previous studies have shown that expression 
of TBR2 was found specifically in IPCs in lissencephalic rodent brain (Englund et al., 2005). 
In gyrencephalic ferret or primates, TBR2 labeled IPCs, and almost half of SOX2+, PAX6+ 
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bRGC population (Betizeau et al., 2013; Fietz et al., 2010; Florio and Huttner, 2014; Hansen et 
al., 2010; Turrero Garcia et al., 2016). Furthermore, in rodent cortex, IPCs are predominately-
neurogenic progenitors. However, in gyrencephalic species, IPCs are capable of self-
amplification through symmetric proliferative divisions before their terminal division to 
generate neurons (Florio and Huttner, 2014; Lui et al., 2011). Beyond simply marking IPCs as 
transient progenitor cell type, future studies may have to relate and delve into the heterogeneity 
in the molecular milieu of IPCs in different species to afford elucidation of their contributions 
to cortical morphogenesis. 
Advances in genetics and genomics studies in recent times have made it possible to 
identify many genetic coding and non‐coding variants that cause neurodevelopmental disorders 
(D'Gama and Walsh, 2018; Hu et al., 2014; Juric-Sekhar and Hevner, 2019), with increased 
risk of neuropsychiatric disturbances (Sestan and State, 2018; Sullivan and Geschwind, 2019). 
Although we now have better insights into the genetic architecture of neuropsychiatric 
perturbations, we still lack a comprehensive description of the underlying molecular and 
cellular mechanisms, mainly because of the heterogeneity of risk loci, and the involvement of 
multiple cell types and brain regions. Therefore, knowledge of the regulatory networks and the 
spatiotemporal distribution of these networks in the brain, is essential for elucidating which cell 
types are relevant in the etiology and possible treatment of these neurodevelopment- and 
neuropsychiatry-related disorders. Moreover, the clarification of the mechanistic underpinnings 
of any given neurological disorder also requires detailed understanding of the developmental 
events that are disrupted in the course of the disease, non-genic causatives (environmental or 
epigenetic) of the anomalies, and dissection of the eventual phenotype. 
Gene co‐expression analyses have also revealed that the developing human (Kang et al., 
2011; Miller et al., 2014; Pletikos et al., 2014) or mouse (Loo et al., 2019) brain transcriptome 
can be organized into distinct co‐expression networks with often prominent spatiotemporal 
patterns, and enriched for distinct biological functions. By probing the transcriptome of mouse 
IPCs and performing further analysis in the form of phenotype association categorization, we 
found strong connection between the identified IPC genes and known human 
neurodevelopmental disorders (Fig. 2.5). This can be explained by the essential role of IPCs in 
cortical development. A great proportion of cortical neurons can be traced to IPCs. IPC-derived 
neurons predominately form the upper cortical layers and their axons constitute the large 
interhemispheric commissural system (i.e., the corpus callosum). Cortical expansion and 
evolutionary changes have been attributed to the tremendous neurogenic output of TBR2-
expressing IPCs and their diversity, especially in human. It is mainly for these reasons that 
disruption in the production of IPCs can lead to a wide range of cortical malformations and 
diverse neurological perturbations in the mammalian cortex. Our data thus suggest that disease-
linked mutations of IPC genes might form robust groupings based on their GO profiles. These 
diseases clearly link to neurodevelopmental defects, e.g. cortical size-associated disorders 
(microcephaly, macrocephaly, and abnormal cortical gyration), corpus callosum defects 
(dysplastic, agenesis, aplasia, hypoplasia of corpus callosum, and abnormality of the cerebral 
white matter), and neurological deficits (intellectual disability, psychomotor developmental 
delay, schizophrenia, autism, and epilepsy). 
Despite the recent great interest in elucidating the principles underlying the IPC-
mediated evolutionary expansion of the neocortex and the consequence of related 
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dysregulation, relatively less attention is accorded to dissecting disease-linked mutations of IPC 
genes to elucidate the pathophysiology of the attendant neurological disorder. By employing 
mouse model for the novel IPC gene Esco2, we were able to identify that IPCs may centrally 
rely on ESCO2 for survival and maintenance of their pool in the developing cortex. The absence 
of ESCO2, which is rather needed for the correct segregation of chromatids and therefore the 
genetic material into the progenies of dividing IPCs, may have triggered the massive apoptosis 
of the resultant ESCO2-deficient IPCs and the resultant overt cortical dysgenesis. Interestingly, 
Esco2 mutations in human have been linked to neurological phenotypes, including 
microcephaly and cognitive deficits. The said pivotal role played by ESCO2 in IPC genesis and 
cortical morphogenesis recapitulated similar critical function of TBR2 in brain morphogenesis. 
Mutations that abolish Tbr2 expression can cause severe neurodevelopmental abnormalities, 
including microcephaly, severe motor and cognitive delay, hypotonia, callosal agenesis, 
polymicrogyria, and cerebellar hypoplasia in rodent (Arnold et al., 2008; Sessa et al., 2008) and 
human (Baala et al., 2007). For future studies, linkage mapping and/or exome sequencing in 
human is expected to identify more IPC-related mutations and dysregulated genes associated 
with aberrant cortical architecture and growth. 
To minimize gender bias in sampling for RNA-seq, we altogether used tissue from 15 
embryos for 3 replicates. In addition, to examine the relative gender contribution in our samples, 
we compared the expression of chromosome X (Xist, Pgk1, Hprt, Eif2s3x) and chromosome Y 
(Ddx3y, Eif2s3y) - located genes, which are known housekeeping genes in the developing 
forebrain (Cheung et al., 2017; Dewing et al., 2003). The comparison revealed their comparable 
expression level in samples from TBR2+ IPCs and TBR2- cells (Fig. S2.1C). The data suggests 
that TBR2+ and TBR2- cell populations were derived from a similar number of female and 
male embryos. Nevertheless, the expression pattern of chromosome X/Y-located IPC genes 
should be validated by either IHC or ISH afore further investigation. 
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Chapter 3: Post-transcriptional regulation by the exosome complex is 
required for cell survival and forebrain development via repression of P53 
signaling 
 
All elements in this chapter have already been published in: 
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U., Fischer, A., Nguyen, H.P., Staiger, J.F., Tuoc T.  (2021). Post-transcriptional regulation by 
the exosome complex is required for cell survival and forebrain development via repression of 
P53 signaling. Development 148(3), dev188276. 
 
Personal contributions: I was involved in conducting the experiments, data analyses, and 
writing of the manuscript. 
 
3.1 Abstract 
Fine-tuned gene expression is crucial for neurodevelopment. The gene expression program is 
tightly controlled at different levels, including RNA decay. N6-methyladenosine (m6A) 
methylation-mediated degradation of RNA is essential for brain development. However, m6A 
methylation impacts not only RNA stability, but also other RNA metabolism processes. How 
RNA decay contributes to brain development is largely unknown. Here, we show that 
EXOSC10, a RNA exonuclease subunit of the RNA exosome complex, is indispensable for 
forebrain development. We report that cortical cells undergo overt apoptosis, culminating in 
cortical agenesis upon conditional deletion of EXOSC10 in mouse cortex. Mechanistically, 
EXOSC10 directly binds and degrades transcripts of the P53 signaling-related genes, such as 
AEN and BBC3. Overall, our findings suggest a crucial role for EXOSC10 in suppressing the 
P53 pathway, in which the rapid turnover of the apoptosis effectors AEN and BBC3 mRNAs is 
essential for cell survival and normal cortical histogenesis. 
 
3.2 Introduction 
The neocortex of the mammalian brain is radially structured into six neuronal layers and 
multiple functional domains that form the structural basis for sensorimotor processing and 
intellectual ability. In early cortical development, apical progenitors (APs) in the ventricular 
zone (VZ) function as neural stem cells (NSCs) and produce neurons via direct and indirect 
neurogenesis in a specific temporal order, which will make up the different cortical layers (Gotz 
and Huttner, 2005; Kriegstein et al., 2006). In direct neurogenesis, APs divide asymmetrically 
to generate new Aps and neurons. Neurons produced during early neurogenesis are distributed 
mainly in the lower cortical layers (LLs) L6 and L5. In indirect neurogenesis, APs divide to 
self-renew and produce basal progenitors (BPs) that undergo limited cycles of symmetric 
divisions to generate more neurons with upper layers (ULs) L4-L2 (Pontious et al., 2008). 
Optimal regulation of gene expression is crucial for establishing the intricate balance 
between the rate of proliferation and differentiation of neural progenitor cells as well as cell 
viability and apoptosis. Transcriptional regulation plays a central role in controlling gene 
expression. However, regulation of gene expression is not limited to the transcriptional level. 
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Posttranscriptional mechanisms, such as the regulation of RNA stability contribute in 
sharpening the expression of genes during development. 
The evolutionarily conserved RNA exosome is an essential factor that modulates gene 
expression during development (Januszyk and Lima, 2014; Kilchert et al., 2016). The ring-like 
structured exosome complex contains 11 different exosome component (EXOSC) subunits, 
including nine structural subunits (EXOSC1-9) and two catalytic subunits (EXOSC10, DIS3) 
(Januszyk and Lima, 2014; Kilchert et al., 2016). Together with structural counterparts, 
EXOSC10 and DIS3 are able to degrade numerous RNAs using their ribonuclease activity. This 
makes the entire exosome complex indispensable for controlling the richness of RNAs, 
degrading malfunctional or mis-configured RNAs. The integrated EXOSC subunits, which 
interact through composite surfaces with their co-factors, are essential for targeting the exosome 
to specific RNAs for degradation, therefore conferring functional specificity (Januszyk and 
Lima, 2014; Kilchert et al., 2016; Lim et al., 2017; Lubas et al., 2011; Puno and Lima, 2018; 
Schmid and Jensen, 2019). 
Of note, mutations of the EXOSC genes have been found in various human brain 
disorders, including corpus callosum hypoplasia, cerebellar atrophy, abnormal myelination, 
pontocerebellar hypoplasia with cerebellar and spinal motor neuron degeneration, and 
intellectual disability (Boczonadi et al., 2014; Burns et al., 2018; Di Donato et al., 2016; Fasken 
et al., 2020; Morton et al., 2018; Wan et al., 2012), suggesting important roles for the exosome 
complex in neural development. 
To investigate the possible involvement of the exosome complex in brain development, 
we used a conditional knockout (cKO) of the RNA exonuclease subunit EXOSC10 from early 
brain development in transgenic mice. Transcriptional profiling of the EXOSC10cKO cortical 
tissue revealed that EXOSC10 suppresses the expression of large sets of genes involved in 
various processes of brain development, including cell death-related pathways. RIP-seq and 
RNA degradation analyses uncovered that EXOSC10 directly binds to and induces degradation 
of P53 signaling-related transcripts. Phenotypically, we found that elimination of EXOSC10 
leads to a massively enhanced apoptosis, reduced neurogenesis and dysgenesis of cortical 
layers, with the first effect being rescued by inhibition of P53 signaling. Overall, this study 
provides new insights into the post-transcriptional regulatory mechanism mediated by the RNA 





3.3.1 Expression of EXOSC10 is indispensable for forebrain development and formation 
of cortical layers 
Mutations in human EXOSC2, EXOSC3, EXOSC8 and EXOSC9 genes, and their associated 
brain disorders imply important roles for the exosome complex in neurodevelopment 
(Boczonadi et al., 2014; Di Donato et al., 2016; Wan et al., 2012). In further support of the 
involvement of the exosome complex in mammalian brain development, exosome genes are 
prominently expressed in the developing mouse cortex, especially in the ventricular zone (VZ) 
(Fig. 3.1A; Fig. S3.1A-J). Extracting the published scRNA-seq dataset of the mouse developing 
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cortex (Telley et al., 2016) also confirmed the highest expression of exosome genes in apical 
progenitors (APs), which are found in the VZ (Fig. 3.1B; Fig. S3.1K-S). As EXOSC10 is the 
exonuclease subunit of the RNA exosome complex (Fig. S3.1A), we aimed to study the role of 
EXOSC10 in neural development by generating and characterizing the cortical phenotype of 
EXOSC10 conditional knockout (cKO) mice.  
To investigate the consequences of loss of EXOSC10 in brain development, we bred 
mice bearing conditional inversion (COIN) alleles of EXOSC10 (Economides et al., 2013; 
Pefanis et al., 2015) with different Cre lines, including telencephalon-specific FoxG1-Cre 
(Hebert and McConnell, 2000) and cortex-specific Emx1-Cre (Gorski et al., 2002), to generate 
the corresponding cKO mutants: cKO_FoxG1-Cre and cKO_Emx1-Cre. Telencephalon-
specific cKO_FoxG1-Cre embryos exhibited an absolute absence of the telencephalon at E17.5 
(Fig. S3.2A, arrow). To examine formation of the telencephalon at early stages, 
immunohistochemistry analysis was performed with antibodies against SOX2, PAX6, HUCD 
and NEUN in forebrain tissue of control and cKO_FoxG1-Cre embryos between E10.5 and 
E12.5 (Fig. S3.2B,C). The expression of these markers was found in telencephalon (Tel), 
diencephalon (Di) and mesencephalon (Mes) of control embryos, whereas their expression was 
seen only in Di and Mes structures in cKO_FoxG1-Cre mutants. This finding suggests that the 
deletion of EXOSC10 at the onset of telencephalon formation in cKO_FoxG1-Cre embryos 
results in the failure of telencephalon formation, which makes this mouse line inappropriate for 
further investigations. At P6, the cortex in cKO_Emx1-Cre mice was significantly smaller than 
that of the control mice; however, we were still able to examine cortical development under 
EXOSC10 deficiency (Fig. 3.1C,D).  
The cKO mutants at P6 had visually smaller cortical size and thinner cortical layers than 
that of controls, as revealed by SATB2 immunostaining (Fig. 3.2A,G). To explore cortical layer 
formation in detail, we performed immunohistochemistry and evaluated the expression of 
cortical layer (L)-specific markers, such as REELIN (L1; Fig. 3.2B), CUX1 (L2/3; Fig. 3.2C), 
CTIP2 (L5; Fig. 3.2D), SOX5 (L5/6; Fig. 3.2E) and TBR1 (L6; Fig. 3.2F). 
The population of REELIN+ L1 neurons generated in the cortical hem and ventral 
telencephalon, where the Emx1 promoter is not active (Gorski et al., 2002), seems to be 
preserved in the cortex of cKO_Emx1-Cre mutants (Fig. 3.2B,G). In contrast, the numbers of 
CUX1+ L2/3, CTIP2+ L5, SOX5+ L5/6 and TBR1+ L6 neurons, which are generated from 
cortical progenitors, were significantly reduced in the cKO_Emx1-Cre cortex (Fig. 3.2C-G). 
Together, these results show that the expression of EXOSC10 is required for normal forebrain 
development and cortical layer formation. 
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Figure 3.1 The expression of EXOSC10 is indispensable for cortical development. 
(A,B) In situ hybridization analysis of sagittal sections obtained from GenePaint database (Visel et al., 2004) (A) 
and in scRNA-seq analysis (Telley et al., 2016) (B) of the E14.5 mouse cortex reveal that EXOSC10 is widely 
expressed, with its highest level seen in apical progenitors (AP, in B) in the ventricular zone (VZ, in A). (C) At 
P6, the cortex in cKO_Emx1-Cre mice is distinctly smaller than that of controls. (D) Quantification of the cortical 
proportions in cKO_Emx1-Cre mice relative to control showing significant differences. AP, apical 
progenitors/RGCs; BP, daughter basal progenitors/IPCs; EN, early-born neurons; LN, late-born neurons; CP, 
cortical plate; SVZ, subventricular zone; VZ, ventricular zone. ***P<0.005. Scale bars: 1 mm. 
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Figure 3.2 Loss of neurons and a reduction in the thickness of cortical layers in postnatal EXOSC10cKO 
mutants. 
(A-F) Immunohistochemistry showing cortical expression of neuronal markers specific for certain cortical layers: 
SATB2 (all layers, A), REELIN (layer 1, B), CUX1 (layer 2/3, C), CTIP2 (layer 5, D), SOX5 (layer 5/6, E) and 
TBR1 (layer 6, F) in coronal sections of EXOSC10cKO and control at P6. Right images are higher magnifications 
of fields indicated by white frames. (G) Quantification of the neuronal markers in EXOSC10cKO cortex at P6 
relative to control. The cells were counted in the dorsal area at the rostral levels shown in A. **P<0.01, 
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3.3.2 EXOSC10 ablation in early cortical development causes massive apoptosis 
The diminished population of neurons in the cKO cortex at postnatal stage promoted us to 
investigate the consequences of the loss of EXOSC10 expression on neurogenesis at early 
embryonic stages. Consistent with the decreased number of neurons in cortical layers at P6 (Fig. 
3.2), the EXOSC10-ablated cortex at E13.5 displayed a diminished number of HUCD+ and 
NEUN+ neurons in cortical plate (CP) (Fig. 3.3A,B,D,E). Remarkably, the thickness of the 
germinal zones, i.e. the ventricular zone (VZ) and sub-ventricular zone (SVZ) (Fig. 3.3A-C), 
in the control cortex was comparable with that of the mutant cortex (Fig. 3.3A,B). Accordingly, 
the number of apical progenitors (PAX6+ or SOX2+) in VZ and basal progenitors (TBR2+) in 
SVZ was comparable in cKO and control cortices (Fig. 3.3A-E). These findings suggest that 
the deletion of EXOSC10 might lead to an enhanced apoptosis or defect in neuronal 
differentiation in early cortical development, causing the observed brain microcephaly at the 
postnatal stage. 
The immunohistochemical analysis with the apoptosis marker activated caspase 3 
(CASP3) revealed that EXOSC10 ablation engenders intense apoptosis in 
EXOSC10cKO_Emx1-Cre cortex at E13.5, especially in the rostromedial area (Fig. 3.4A-C), 
where the Cre recombinase activity was found to be highest (Gorski et al., 2002; Narayanan et 
al., 2015; Nguyen et al., 2018). A dramatic increase in apoptosis was already evident in the 
mutant cortex at E11.5 (Fig. 3.4D). Apoptotic cells were observed in the entire mutant cortex, 
albeit more dominant in the basal side of cortical wall, suggesting that neurons were the most 
affected population of cells therein (Fig. 3.4A-C). Notably, there was no difference in the 
number of CASP3+ apoptotic cells between control and EXOSC10cKO cortices at postnatal 
stages, indicating that EXOSC10 expression is required for cell viability only at embryonic 
stages of cortical development (Fig. S3.3). 
Double immunohistochemical analyses of CASP3 and markers for apical progenitors 
(SOX2; Fig. 3.4A), basal progenitors (TBR2; Fig. 3.4B) and neurons (NEUN; Fig. 3.4C) 
confirmed that apoptosis was found in all three cell populations in the cKO_Emx1-Cre cortex 
(indicated by filled arrows in Fig. 3.4A-C, E). Notably, the highest cell death rate was identified 
in NEUN+ neurons (Fig. 3.4E). Altogether, our findings indicate that EXOSC10 is crucial for 
cell viability in early cortical development. 
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Figure 3.3 A reduced thickness of the cortical plate but normal pools of cortical progenitors in 
EXOSC10cKO cortex at E13.5. 
(A,B) Double immunohistochemical analyses with antibodies that specifically mark NSCs [PAX6 (A) and SOX2 
(B)] and neurons [HUCD (A) and NEUN (B)] in the EXOSC10cKO cortex and control at E13.5. For each, rostral 
and caudal sections are shown. Lower images are higher magnifications of fields indicated by the red frame. In 
cKO cortex, many PAX6+ and SOX2+ cells were also immunoreactive to HUCD and NEUN (A and B, white 
arrows). (C) Immunohistochemistry showing cortical expression of the intermediate progenitor marker TBR2 in 
the E13.5 EXOSC10cKO and control cortex. (D,E) Quantification of cells expressing neuronal progenitor genes 
(SOX2 and PAX6) and neuronal genes (NEUN and HUCD) in the E13.5 cKO cortex relative to control at rostral 
(D) and caudal (E) levels. CP, cortical plate; SVZ, subventricular zone; VZ, ventricular zone. *P<0.05, **P<0.01, 
***P<0.005; NS, not significant. Scale bars: 200 μm and 100 μm (higher magnification). 
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Figure 3.4 EXOSC10 ablation in early cortical progenitors causes massive apoptosis. 
(A-C) Double immunohistochemical analyses for the apoptosis marker activated caspase 3 (CASP3) together with 
SOX2 for NSCs (A), TBR2 for IPs (B) or NEUN for neurons (C) in the EXOSC10cKO cortex and control at 
E13.5. Middle images are higher magnifications of fields indicated by the red frame. White arrows indicate cells 
co-expressing CASP3 and the cell type marker; empty arrows indicate cells expressing only CASP3. (D) 
Quantification of apoptotic cells in EXOSC10cKO cortex and control at E11.5, E12.5 and E13.5. (E) 
Quantification of apoptosis in different cell types by counting CASP3+ cells among SOX2-, TBR2- or NEUN-
expressing cells in the E13.5 cKO and control cortex. CP, cortical plate; SVZ, subventricular zone; VZ, ventricular 
zone. **P<0.01, ***P<0.005; NS, not significant. Scale bars: 200 μm and 100 μm (higher magnification). 
 
3.3.3 Identification of EXOSC10 target genes 
To understand the molecular mechanisms underlying control of cortical development by 
EXOSC10 and to identify the EXOSC10 direct target transcripts, RNA sequencing (RNA-seq) 
as well as RNA immunoprecipitation sequencing (RIP-seq), were performed. In the RNA-seq, 
RNAs isolated from the E12.5 EXOSC10cKO_Emx1-Cre and control cortices were sequenced 
(Fig. S3.4A,C). We found that loss of EXOSC10 caused upregulation of 1031 genes and 
downregulation of 844 genes (adjusted P<0.05; Fig. 3.5A, Table S1). Gene ontology (GO) 
analysis of the upregulated genes reflected involvement of various brain development processes 
(Fig. 3.5B, Table S2). Consistent with the increased apoptosis, cell death-related pathways, 
such as regulation of apoptotic signaling pathway, and signal transduction by P53 mediators 
were upregulated in the cKO cortex (Fig. 3.5C, Table S2). 
In our RIP-seq experiment, RNAs were purified from the E12.5 wild-type mouse cortex 
(Fig. S3.4B,D). By sequencing the EXOSC10-bound RNAs, binding enrichment of EXOSC10 
on 3159 transcripts was identified (adjusted P<0.05; Fig. 3.5B, Table S3). GO analysis revealed 
that the EXOSC10-bound transcripts participate in various processes of brain development 
(Fig. 3.5D, Table S4). To identify candidates for functional analysis, we compared the RNAs 
upregulated in the EXOSC10cKO cortex in RNA-seq experiment with transcripts bound by 
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EXOSC10 in RIP-seq analysis. We identified 144 transcripts common to the results of both 
experimental analyses (Fig. 3.5E, Table S5). Interestingly, those intersectional 144 upregulated 
genes showed an enrichment in the GO term ‘neuron death’ (Fig. 3.5F, Table S6).  
In accordance with our immunohistochemical data showing increased numbers of 
CASP3+ apoptotic cells, many genes involved in P53 apoptosis signaling (e.g. Ccng1, Sesn2, 
Pmaip1, Bbc3 and Aen) were upregulated in the cortex of EXOSC10cKO mutants (Fig. 3.5A; 
Fig. 3.6B). Furthermore, the results from our RIP-seq analysis revealed that transcripts of many 
apoptosis-related genes (e.g. Ccne1, Ccng2, Tsc2, Bbc3, Apaf1 and Aen) were bound by 
EXOSC10 (Fig. 3.5B; Fig. 3.6A). Thus, our findings raise the possibility that EXOSC10 
inhibits apoptosis by directly suppressing expression of P53 signaling effector genes. 
 59  
 
Figure 3.5 EXOSC10 controls global gene expression in early cortical development. 
(A,B) Volcano plot and heatmap showing significant changes in gene expression (A) and transcript-binding 
enrichment (B) revealed by RNA-seq (E12.5 EXOSC10cKO cortex versus control) and RIP-seq (E12.5 cortex, 
EXOSC10 antibody versus IgG) analyses, respectively. (C,D) Gene ontology analysis of genes upregulated in 
RNA-seq (C) and transcript-binding enrichment in EXOSC10 RIP-seq (D). (E) The overlap between upregulated 
genes in RNA-seq of E12.5 EXOSC10cKO cortices and transcript-binding enrichment in EXOSC10 RIP-seq. (F) 
Gene ontology analysis of upregulated genes in RNA-seq and their transcript bound by EXOSC10 in RIP-seq. 
 
Figure 3.6 EXOSC10 suppresses the expression of P53 pathway AEN and BBC3 genes by degrading their 
transcripts. 
(A) RIP-seq analysis with RNA from E12.5 mouse cortex revealed the binding of EXOSC10 to P53 pathway 
transcripts. (B,C) The upregulated genes in EXOSC10cKO_Emx1-Cre cortex at E12.5, which are involved in P53 
signaling, were identified by RNA-seq (B) and confirmed by qPCR (C). (D,E) Immunohistochemistry (D) and 
quantitative analyses (E) for expression of AEN on coronal sections of control and EXOSC10cKO cortices at 
E11.5 are shown. (F) Experimental paradigm for the RNA degradation assay using cultured cortical NSCs. (G,H) 
RNA degradation assay showing changes in the RNA abundance of AEN (G) and BBC3 (H) measured by qPCR 
from EXOSC10 KO NSCs and control NSCs after actinomycin D treatment for 0 h, 5 h and 17 h. BG, basal 
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ganglia; CP, cortical plate; dCx and mCx, dorsal and medial cortex; VZ, ventricular zone. *P<0.05, **P<0.01, 
***P<0.005; NS, not significant. Scale bar: 100 μm. 
3.3.4 P53 pathway genes Aen and Bbc3 are direct targets of EXOSC10 in the developing 
cortex 
Among the transcripts belonging to the P53 pathway, AEN (apoptosis enhancing nuclease) and 
BBC3 (BCL2 binding component 3; also known as PUMA, P53-upregulated modulator of 
apoptosis) were bound by EXOSC10 (Fig. 3.6A). Their upregulated expression in the 
EXOSC10cKO cortex was first revealed by RNAseq (Fig. 3.6B), then confirmed by qPCR (for 
BBC3, AEN and Atr; Fig. 3.6C) and immunohistochemical analyses (for AEN; Fig. 3.6D,E), 
making them strong candidates for mediating regulation of apoptosis by EXOSC10. 
To ascertain the functional effect of EXOSC10 binding, we examined whether 
EXOSC10 deletion influences decay of these identified transcripts. For this purpose, an RNA 
degradation assay was performed using cultured cortical NSCs derived from E12.5 EXOSC10 
COIN/COIN embryos. NSCs were treated with either soluble Tat-Cre recombinase to knockout 
EXOSC10 (EXOSC10KO) or vehicle as a control group (Fig. 3.6F; Fig. S3.5). An actinomycin 
D-based method was used to halt de novo transcription (Yoon et al., 2017). The cells were 
harvested and qPCR was performed to quantify the transcript level of AEN and BBC3 in 
cultured NSCs before (0 h) and after 5 h and 17 h treatment of actinomycin D (Fig. 3.6F). 
Compared with control, a higher stability of AEN transcripts in EXOSC10KO NSCs was 
observed after 5 h and 17 h treatment of actinomycin D (Fig. 3.6G). The higher RNA stability 
of BBC3 in mutant NSCs than that in controls was seen after 17 h of actinomycin D treatment 
(Fig. 3.6H). These results indicated that EXOSC10 directly binds and degrades transcripts of 
AEN and BBC3. 
To consolidate our observation that EXOSC10 may regulate apoptosis via suppression 
of the P53 apoptosis pathway, in vivo rescue experiments were performed. We used a P53 
inhibitor, pifithrin-α (PFTα), that is known to inhibit P53-dependent activation of P53-targeted 
genes (Komarov et al., 1999). PFTα was injected daily starting from 9.5 days post coitum 
(d.p.c.), and the PFT-treated EXOSC10cKO animals were examined at E13.5 (Fig. 3.7A). 
Whereas 52.0±3.5% of cells in the PFT-untreated (noninjected) EXOSC10cKO cortex were 
apoptotic, the percentage of CASP3+ cells decreased to 31.0±9.2% upon PFTα treatment (Fig. 
3.7B,C). Thus, the observed apoptotic phenotype in EXOSC10cKO mutants was largely 
rescued by inhibition of the P53 pathway in the developing cortex. Among the P53 pathway-
related genes, we compared the expression of Bbc3 and Aen from control and cKO cortices, 
which were treated with either vehicle or P53 inhibitor. Remarkably, PFTα treatment does not 
significantly rescue the aberrant upregulation of AEN upon the loss of EXOSC10 in the 
developing cortex (Fig. 3.7D). Treatment with PFTα, however, decreases the expression of 
BBC3, which is upregulated in cKO cortex (Fig. 3.7E). This is in line with the evidence that 
BBC3 (but not AEN) is a direct target of P53, as the promoter region of BBC3 contains P53-
binding sites and can be directly activated by P53 (Han et al., 2001). 
To address whether EXOSC10 regulates cortical development partly via suppression of 
P53 signaling, pregnant mice between 9.5 and 15.5 days post coitum (d.p.c.) were 
intraperitoneally injected daily with PFTα solution. Owing to the perinatal lethality of PFTα- 
treated animals, the brain samples were collected at E18.5 for phenotype analysis (Fig. 3.8A). 
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The expression of SATB2, which marks the majority of projection neurons in all cortical layers 
and areas (Alcamo et al., 2008; Britanova et al., 2008), was then examined in control, and in 
cKO with and without PFTα treatment. The treatment with P53 inhibitor did not influence the 
size of wild-type (control) cortex, as indicated by SATB2 expression. Remarkably, when 
compared with vehicle-treated cKO embryos, PFTα-treated embryos had a significantly larger 
cortex. Concurrently, PFTα administration in cKO mutants resulted in an increase in the number 
of SATB2+ neurons (Fig. 3.8B-F). The findings indicate that treatment with the P53 inhibitor 
partly rescues the aberrant cortical morphology in mutants. 
Altogether, these results reveal that loss of EXOSC10 during early cortical development 
causes aberrantly enhanced expression of P53 pathway-related transcripts such as AEN and 
BBC3, and causes increased apoptosis similar to that observed after P53 overexpression (Fig. 
3.8G). These findings demonstrate that the balance between the RNA exosome complex and 
P53 signaling activity is essential for cell survival and for normal cortical development (Fig. 
3.8G). 
Figure 3.7 EXOSC10 suppresses apoptosis by inhibiting activity of P53 signaling pathway. 
(A) Rescue experimental paradigm with the P53 inhibitor (PFTα). (B,C) Immunohistochemistry (B) and 
quantitative analyses (C) for the apoptosis marker CASP3 on coronal sections of E13.5 control and 
 62  
 
EXOSC10cKOcortices with or without PFTα treatment. Lower images are higher magnifications of field indicated 
by the red frame (B). The ratio of CASP3+ cells to all DAPI+ cells was assessed in control and EXOSC10cKO 
cortices with or without PFTα treatment, showing a reduction in CASP3+ cells in the cKO upon injection (C). 
(D,E) Treatment with PFTα decreases the expression of BBC3 (E), but not that of AEN (D), which is upregulated 
in cKO cortex. *P<0.05, **P<0.01, ***P<0.005; NS, not significant. Scale bars: 200 μm and 100 μm (higher 
magnification. 
Figure 3.8 EXOSC10 controls cortical development partly by suppressing P53 signaling activity. 
(A,B) Rescue experimental paradigm (A) to examine effect of P53 signaling inhibitor (PFTα) on the SATB2+ 
cortical area (B). (C-F) Immunohistochemistry with SATB2 antibody (C) and quantitative analyses (D-F) of cKO 
mutants at E18.5, showing the effects of treatment with PFTα on the SATB2+ cortical area at rostral (D) and 
caudal (E) levels, and on the pool of SATB2+ projection neurons at the caudal level (F). (G) A proposed model 
showing how the balanced level of RNA exonuclease EXOSC10 and the P53 signaling factors AEN and BBC3 
ensures cell survival, whereas the loss of EXOSC10 causes accumulation of AEN and BBC3, leading to apoptosis. 
*P<0.05, **P<0.01, and ***P<0.005; NS, not significant. Scale bar: 200 μm. 
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3.4 Discussion 
Here, we have investigated the possible function of the RNA exonuclease EXOSC10 in brain 
development. We demonstrate that expression of EXOSC10 is crucial for controlling cell 
survival and cortical development. Our findings indicate that EXOSC10 performs an essential 
function in controlling P53-mediated apoptosis signaling by directly degrading the P53 
signaling-related transcripts such as AEN and BBC3 (Fig. 3.8G). 
 
3.4.1 Emerging roles of RNA stability regulation in brain development 
Post-transcriptional regulations such as RNA modification and RNA stability are emerging as 
mechanisms that are essential for regulation of gene expression. The best known mechanism of 
RNA modification, so far, is the methylation of nitrogen 6 in adenosine (N6-methyladenosine, 
m6A). The m6A writer complex, consisting of RBM15, WTAP, METTL3 and METTL14, is 
responsible for addition of methyl groups to RNA (Liu et al., 2014; Wang et al., 2016). On the 
other hand, the m6A eraser Alkbh5 can remove methyl groups installed on RNA (Zheng et al., 
2013). YTH proteins and eIF3 can serve as m6A readers to recognize m6A (Meyer et al., 2015; 
Patil et al., 2016). Recent studies suggest important roles for m6A methylation in the 
modulation of RNA stability in brain development (Flamand and Meyer, 2019; Li et al., 2018b; 
Wang et al., 2018; Widagdo and Anggono, 2018; Yoon et al., 2017). 
m6A deficiency by METTL14 cKO in the developing mouse brain increased the 
stability of NSC transcripts, causing lengthening of the cell cycle of NPCs and prolongation of 
cortical neurogenesis further at postnatal stage (Yoon et al., 2017). The m6A depletion by 
METTL14 cKO also changed the levels of modified histones and of transcripts encoding 
histone-modifying enzymes, indicating that m6A-dependent control of epigenetic program 
alterations is involved in neurodevelopment (Wang et al., 2018).  
Deletion of m6A reader YTHDF2 in YTHDF2 KO mice leads to late embryonic 
lethality. Neurogenesis was declined significantly with concurrent reduction in the number of 
TBR2+ BPs leading to a thinner cortical plate in YTHDF2 KO embryos (Li et al., 2018b). It 
should be noted, however, that m6A was shown to impact not only RNA stability but also other 
features of RNA metabolic processes, such as translation, splicing and transport of RNA 
(Dominissini et al., 2012; Meyer et al., 2012; Wang et al., 2014; Wang et al., 2015; Xiao et al., 
2016). Thus, the precise roles of RNA stability in brain development are still largely unknown. 
Functional investigations of genes encoding exosome subunits in model systems 
indicated that most exosome subunits are required for viability from yeast to man (Fasken et 
al., 2020; Januszyk and Lima, 2014; Kilchert et al., 2016; Morton et al., 2018). Although the 
precise role of the exosome complex in neural development is not known, mutations in four out 
of the 11 exosome subunit genes in humans have been found to be associated with 
neurodevelopmental and psychiatric disorders. Notably, mutations in EXOSC2 are associated 
with intellectual disability (Di Donato et al., 2016), whereas mutations in EXOSC3 (Eggens et 
al., 2014; Halevy et al., 2014; Rudnik-Schoneborn et al., 2013; Wan et al., 2012; Zanni et al., 
2013), EXOSC8 (Boczonadi et al., 2014) and EXOSC9 (Burns et al., 2018) cause different 
types of cerebellar hypoplasia that lead to severe neurodegeneration and lethality. Mutations of 
these exosome factors were also associated with other brain defects, such as corpus callosum 
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hypoplasia, cerebellar atrophy and abnormal myelination, as well as pontocerebellar hypoplasia 
with cerebellar and spinal motor neuron degeneration (Boczonadi et al., 2014; Burns et al., 
2018; Di Donato et al., 2016; Eggens et al., 2014; Halevy et al., 2014; Rudnik-Schoneborn et 
al., 2013; Wan et al., 2012; Zanni et al., 2013). The findings in these human genetics studies 
indicate that the RNA exosome is crucial for normal neural development and cognition (Fasken 
et al., 2020; Morton et al., 2018). 
Among EXOSC subunits, the role of EXOSC10 in biological processes is the most 
investigated. EXOSC10 has been shown to stimulate mRNA turnover (van Dijk et al., 2007), 
3′ pre-rRNA processing (Knight et al., 2016), and decay of long non-coding and enhancer 
RNAs (eRNAs and lncRNAs) (Pefanis et al., 2015) with its absence causing RNA processing 
defects in yeast (Carneiro et al., 2007) and increased vulnerability to DNA damage (Domingo-
Prim et al., 2019; Marin-Vicente et al., 2015; Rolfsmeier et al., 2011). EXOSC10 functions 
with a co-factor, such as the NEXT complex, that recognizes and degrades RNA in DNA/RNA 
hybrid or RNA/RNA hybrid configuration, or eRNAs/lncRNAs (Lim et al., 2017; Lubas et al., 
2011; Puno and Lima, 2018; Schmid and Jensen, 2019). Studies in cultured cell lines and in 
transgenic mice show that human EXOSC10 is crucial for cell cycle (Blomen et al., 2015). 
More recent in vivo work reported that EXOSC10 controls the onset of spermatogenesis in male 
germ cells (Jamin et al., 2017). Accordingly, EXOSC10cKO mutant mice show small testes 
and impaired differentiation of germ cells, and exhibit reduced fertility (Jamin et al., 2017). 
However, whether or not EXOSC10 is essential for brain development has remained unclear. 
Our findings reveal that the function of EXOSC10 is required for the development of the 
forebrain. During early corticogenesis, EXOSC10 is indispensable for cell viability and cortical 
layer formation. The requirement of the exosome complex in cell survival identified using the 
EXOSC10cKO_Emx1-Cre cortex could possibly explain the aforementioned 
neurodegeneration caused by mutations of human EXOSC genes. 
The ring-like structured exosome complex contains eleven evolutionarily conserved 
subunits, including nine structural subunits (EXOSC1-9) and two catalytic subunits (EXOSC10 
and DIS3) (Januszyk and Lima, 2014; Kilchert et al., 2016). The expression pattern analysis 
(Fig. S3.1B-J) revealed that many exosome subunits (e.g. EXOSC1, EXOSC2, EXOSC3, 
EXOSC5, EXOSC9 and EXOSC10) are widely expressed in developing mouse cortex. 
Remarkably, expression of some subunits is found to be limited to the VZ (EXOSC8) or SVZ 
(EXOSC7). This raises the question of whether all the components are required for the RNA 
exonuclease activity of the exosome complex. Even though our understanding of the functions 
of the exosome complex and its subunits in development has improved, several key questions 
remain unanswered. For example, is the composition of the exosome complex restricted to 
eleven subunits? Also, what is the contribution of individual subunits in formation and action 
of the exosome complex? Whether lineage-restricted subunits exist that lead to dynamic 
combinatorial assembly of exosome complexes, producing their biological specificity, remains 
to be determined. Efforts to resolve these and other questions would stimulate continuous 
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3.4.2 P53 pathway genes Aen and Bbc3 are targets of EXOSC10 in developing cortex 
P53 is a well-known master regulator of numerous developmental events. It triggers expression 
of various downstream genes, some of which promote growth arrest and DNA repair, whereas 
others are involved in apoptosis (Jain and Barton, 2018; Mendrysa et al., 2011). The massive 
apoptosis observed in the early developing cortex of EXOSC10cKO_Emx1-Cre embryos 
culminated in a severe reduction of cortical size. 
To gain a transcriptome-wide insight into the role of exosome complex in 
corticogenesis, we carried out RNA-seq analysis of cKO cortices and EXOSC10 RIP-seq. Our 
findings revealed upregulation of several genes associated with the P53 apoptosis pathway. 
Interestingly, cardinal components of apoptosis-associated P53 signaling, AEN (Kawase et al., 
2008) and BBC3 (Han et al., 2001; Jeffers et al., 2003), were identified in our RNA-seq and 
RIP-seq analyses. The RNA degradation assay carried out further highlighted that EXOSC10 
directly degrades transcripts of AEN and BBC3. 
AEN possesses exonuclease activity to degrade both DNA and RNA (Lee et al., 2005). 
In P53 signaling-dependent apoptosis, DNA damage signals lead to translocation of AEN into 
the nucleolus, causing nucleolar disruption (Kawase et al., 2008). Subsequently, AEN degrades 
DNA and RNA, amplifying the damage signal and inducing apoptosis (Kawase et al., 2008). 
The promoter region of BBC3 contains P53-binding sites and can be directly activated by P53 
(Han et al., 2001). BBC3 is part of the BH3-only BCL-2 family proteins, which have been 
found to localize to mitochondria in response to apoptotic stimuli, where they induce 
mitochondrial apoptosis (Huang and Strasser, 2000; Lomonosova and Chinnadurai, 2008). 
BBC3 has been shown to be required for γ-irradiation-induced cell death in the developing 
brain, and P53 is not able to induce apoptosis in the absence of BBC3 (Jeffers et al., 2003). Our 
data also highlight that EXOSC10 regulates cell viability in developing cortex by repressing 
the distinct P53-dependent apoptosis signaling pathways, including those caused by DNA/RNA 
damage and γ-irradiation signals. Notably, PFTα treatment significantly rescues the aberrant 
upregulation of BBC3 (but not AEN) upon the loss of EXOSC10 in the developing cortex (Fig. 
3.7D,E). This proves that BBC3 (but not AEN) is a direct target of P53. 
Previous studies indicated that accumulation of RNA/DNA hybrids or noncoding RNAs 
as eRNAs/lncRNAs could induce cellular genomic instability leading to P53 activation and cell 
death (Pefanis et al., 2015; Wolin and Maquat, 2019). In addition, RNA exosome is important 
for DNA DSB repair as the lack of EXOSC10 leads to accumulation of DNA breaks and P53 
activation (Domingo-Prim et al., 2019; Pefanis et al., 2015). The findings suggest that other 
mechanisms in addition to the increased expression of AEN and BBC3 cause the 
hyperactivation of P53 signaling in response to the defect of RNA exosome activity. 
In addition to the apoptotic P53 signaling pathway, we examined the oxidative stress 
signaling – one of the well-known cell death-triggering pathways in the developing brain 
(Green, 1998; Ikonomidou, 2009). Expression of genes encoding the main components of this 
pathway (e.g. BAX, BH3 and Cytochrome C) was unchanged in our RNA-seq analysis, and the 
pathway itself was not found in a corresponding GO study (Tables S1 and S2). Thus, our 
findings suggest that EXOSC10 inhibits apoptosis mainly by suppressing the activity of the 
apoptotic P53 signaling pathway. 
 66  
 
Pharmacological inhibition of P53 signaling rescued the described defects in cell 
viability in the EXOSC10cKO mutants (Fig. 3.7A-C), suggesting that the EXOSC complex 
negatively regulates P53 signaling during early cortical development. It is worth noting, 
however, that the inhibition of P53 signaling was not able to restore the normal thickness of 
cortical layers in EXOSC10cKO mutants (Fig. 3.7A-C). Therefore, the observed drastic 
reduction in the size of the cortical plate cannot be singularly ascribed to the increased apoptosis 
but other unreported perturbations may contribute to the observed defective neurogenesis. In 
agreement with this assertion, our RNA-seq and RIP-seq data suggest that EXOSC10 might 
directly suppress expression of many neuronal differentiation-associated genes. Possible 
defects in neurogenesis and neuronal differentiation in the cortex-specific EXOSC10cKO 
mutants will be in focus in a separate study. 
Overall, our findings indicate a crucial role for EXOSC10 in P53 pathway-mediated 
apoptosis, in which the binding of EXOSC10 to the mRNAs of the P53 signaling mediators 
AEN and BBC3 confers their rapid turnover. Our study indicates that suppression of P53 
signaling by the exosome complex is essential for normal cell survival and brain development 
(Fig. 3.8G). 
 
3.5 Materials and Methods 
 
3.5.1 Transgenic mice 
Conditional inversion (COIN) alleles for EXOSC10 (COIN/COIN) (Economides et al., 2013; 
Pefanis et al., 2015), FoxG1-Cre (Hebert and McConnell, 2000) and Emx1-Cre (Gorski et al., 
2002) mice (Mus musculus) were maintained in a C57BL6/J background. Animals were 
handled in accordance with the German Animal Protection Law. 
 
3.5.2 Antibodies 
A list of antibodies is provided in the supplementary Materials and Methods. 
 
3.5.3 Immunohistochemistry, western blotting and qPCR 
Detailed descriptions have been provided previously (Narayanan et al., 2015) and more detail 
can be found in the supplementary Materials and Methods. 
 
3.5.4 RNA-sequencing (RNA-seq), RNA-immunoprecipitation sequencing (RIP-seq) and 
bioinformatics analyses 
Detailed descriptions have been provided previously for RNA-seq (Narayanan et al., 2015; 
Nguyen et al., 2018), RIP-seq (Xie et al., 2019; Yoon et al., 2017) and bioinformatics analyses 
(Narayanan et al., 2015; Nguyen et al., 2018). In RNA-seq experiments, RNA was obtained 
from cortex from five control and five EXOSC10cKO embryos at E12.5. cDNA libraries were 
prepared using the TruSeq RNA Sample Preparation v2 Kit. DNA was quantified using a 
Nanodrop spectrophotometer, and its quality was assessed using an Agilent 2100 Bioanalyzer. 
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EXOSC10 RNA-seq was performed using Magna RIP Kit (Merck Millipore) according 
to the manufacturer’s instructions. In brief, dissociated cells from E12.5 cortex on 10 cm dish 
were lysed in 400 μl of complete RIP lysis buffer-containing protease inhibitors and RNase 
inhibitor. EXOSC10 protein was pulled down using a Dynabeads-associated EXOSC10 
antibody. A mock pull-down was carried out with normal rabbit IgG (Cell Signaling 
Technologies). The immunoprecipitated complex was washed intensively and the pulled down 
RNA was extracted using Trizol reagent. Purified RNA was sequenced at the Transcriptome 
and Genome Analysis Laboratory (TAL) (University of Goettingen, Germany). 
Data obtained from RNA- and RIP-seq were processed with the help of the Galaxy web 
platform (Afgan et al., 2018) and further analyzed using Webgestalt 
(http://www.webgestalt.org) (Wang et al., 2013; Wang et al., 2017; Zhang et al., 2005) and 
DAVID Bioinformatics Resources 6.8 (Huang da et al., 2009). Gen sets from RNA- and RIP-
seq were compared using Venny 2.1 (Oliveros). Base calling, fastq conversion, quality control 
and read alignments were all achieved as outlined for RIP-Seq. Reads were aligned to mouse 
genome mm10 and counted using FeaturesCount (http://bioinf.wehi.edu.au/featureCounts/). 
Differential expression was assessed using DESeq2 from Bioconductor (Love et al., 2014). 
Functional GO enrichment analyses were performed using ToppGene (Chen et al., 2009). 
 
3.5.5 Culture and generation of EXOSC10 KO primary NSCs 
Mouse NSCs were isolated from E12.5 EXOSC10 COIN/COIN cortices and cultured in NSC 
culture medium containing KO DMEM/F12 (Invitrogen), StemPro Neural Supplement 
(Invitrogen), Glutamax (Invitrogen), penicillin/streptomycin (Invitrogen), 20 ng/ml FGF2 
(Invitrogen) and 20 ng/ml EGF (Invitrogen) on culture dishes precoated with 0.1% gelatin as 
described previously (Tuoc et al., 2013; Tuoc and Stoykova, 2008). TAT-Cre recombinase 
(Excellgen) (1 μM) was added to fresh NSC culture medium for 26 h to achieve EXOSC10 KO. 
 
3.5.6 RNA degradation assay 
The assay was performed as described previously (Xie et al., 2019; Yoon et al., 2017). Briefly, 
EXOSC10 COIN/COIN mouse NSCs were cultured to about 70-90% confluence. Some wells 
were treated with 1 μM TAT-Cre (Excellgen) 26 h beforehand to achieve EXOSC10 KO; cells 
with vehicle solution served as controls. Actinomycin D (5 mM, Sigma) was supplemented to 
fresh NSC culture medium. Subsequently, cells were harvested at different time points (0 h, 5 
h and 17 h) by washing once with PBS and detaching using Tripsin/ EDTA(Sigma). For 
transcript quantification, RNA was extracted from the NSC samples. qPCR was carried out to 
quantify the transcript level of target genes. The experiment was performed in triplicate and 
normalized to internal 18S. Fold changes of transcript targets between EXOSC10KO and 
control NSCs were compared at different time points (0 h, 5 h and 17 h) after actinomycin D 
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3.5.7 In vivo pharmacological treatment and rescue experiments 
EXOSC10cKO_Emx1-Cre mouse embryos were subjected to the P53- inhibitor Pifithrin-α 
(PFT-α) (Komarov et al., 1999) by intraperitoneal injection of 2.2 mg/kg PFT-α (Selleckchem) 
into the pregnant mother at between E9.5 and E12.5 or between E9.5 and E15.5. Embryonic 
brains were isolated at E13.5 or E18.5 and immunohistochemistry was performed. 
 
3.5.8 Relative quantification of cortical size 
Dorsal views of forebrains of mutant and control mice were photographed under a dissection 
microscope. Cortical anterior-posterior axis (AP), cortical surface and midline lengths from the 
digitized images were measured with Fiji software to make comparison between mutants and 
controls. For further details, see the supplementary Materials and Methods. 
 
3.5.9 Cell counts and quantitative analysis of IHC signal intensity 
IHC quantification was performed using anatomically matched coronal sections. In most cases, 
cell counts of six matched sections were averaged (control/cKO). For quantitative analyses of 
IHC signal intensity of cytoplasm-staining markers, fluorescent images of selected areas of the 
cortex were used. Color images were converted to gray scale and the fluorescent signal intensity 
values were measured using the Analyze/Measure function of Fiji software. The signal intensity 
from the background next to the tissue was subtracted from the measured intensity for 
normalization. For further details, see the supplementary Materials and Methods. 
 
3.5.10 Image acquisition and statistical analysis 
Imaging was performed with an Axio Imager M2 (Zeiss) with a Neurolucida system (Version 
11; MBF Bioscience) and a confocal fluorescence microscope (TCS SP5; Leica). Images were 
further analyzed with Adobe Photoshop and Fiji. Statistical analyses were carried out using 
Student’s t-test. Graphs are plotted as mean±s.e.m. An unpaired t-test was carried out on the 
average from at least three biological replicates. All details of statistical analyses and 
description for histological experiments are presented in Table S7 and in the supplementary 
Materials and Methods. 
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3.11 Supplementary figures 
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Figure S3.1 Expression of exosome complex subunits in the developing mouse brain. 
(A) Model structure of the exosome complex with its components (Kilchert et al., 2016). (B‒J) In situ hybridization 
of exosome complex components in sagittal sections of the E14.5 brains obtained from GenePaint database (Visel 
et al., 2004). Higher magnification of the cortex on right panels shows a high expression of exosome genes in the 
cortex, especially in the ventricular zone (VZ). (K–R) Expression of exosome subunits based on a published single-
cell RNA-seq dataset of embryonic mouse cortex (Telley et al., 2016). The expression profiles of exosome subunits 
as violin plots was generated using the Seurat package of R (http://genebrowser.unige.ch/science2016/) (Macosko 
et al., 2015). AP: Apical progenitors/RGCs; BP: daughter basal progenitors/IPCs; EN: early-born neurons; LN: 
late-born neurons. 
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Figure S3.2 Expression of EXOSC10 is required for specification of telencephalon. 
 (A) The forebrain-specific cKO_FoxG1-Cre embryos have no telencephalon. (B, C) Representative images show 
IHC analyses with coronal sections of head from control and cKO_FoxG1-Cre embryos at E11.5 with antibodies 
against SOX2, NEUN (B) and PAX6, HUCD (C) that specifically label primordial NSC markers SOX2, PAX6, 
and immature neuronal markers NEUN, and HUCD respectively. IHC analyses revealed detectable SOX2+, 
PAX6+ NSCs and HUCD+, NEUN+ neurons in diencephalon (Di) and in mesencephalon (Mes) in both control 
and cKO head, whereas these cell types were detected only in dorsolateral part (telencephalon, Tel) of control, but 
not that of cKO head. Abbreviations: Tel, telencephalon; Di, diencephalon; Mes, mesencephalon. Scale bars = 1 
mm. 
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Figure S3.3 EXOSC10 expression is not required for cell viability in postnatal cortex. 
IHC analysis with antibody against CASP3 to detect cell death (counter staining with DAPI) indicated there was 
no obvious difference in number of CASP3+ apoptotic cells between control and EXOSC10cKO cortices at P6. 
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Figure S3.4 Cluster and Heatmap analyses of RNA-seq and RIP-seq samples. 
IHC analysis with antibody (A, B) cluster dendrogram analysis of all RNA-seq (A, control, EXOSC10cKO) and 
RIP-seq (B, IgG RIP, EXOSC10 RIP) samples. The log2-nomalized values of all the genes were used for cluster 
analysis. (C, D) Heatmaps showing changes in gene expression (C) and transcript binding enrichment (D) revealed 
by RNA-seq (E12.5 EXOSC10cKO cortex vs. control) and RIP-seq (E12.5 cortex, EXOSC10 antibody vs IgG) 
analyses, respectively. Top 25 upregulated/enriched genes and genes involved in P53 apoptosis signaling were 
displayed. Additionally, EXOSC10 was shown as a control. 
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Figure S3.5 Knockout of EXOSC10 using soluble Tat-Cre recombinase in EXOSC10COIN/COIN NSCs and the 
effects of PFTα treatment on BBC3 expression in the developing cortex. 
(A) Western blot (WB) analysis of EXOSC10 expression in EXOSC10COIN/COIN NSCs without Cre (-Cre) as control 
and after 26h of treatment with soluble Tat-Cre recombinase (+Cre). Tubulin is shown as a loading control. (B) 
Quantification of the protein band densities (from A) relative to control (as 100%), which was normalized to 
tubulin. 
3.12 Supplementary materials and methods 
 
3.12.1 Antibodies 
Polyclonal (pAb) and monoclonal (mAb) primary antibodies used in this study (working 
dilution; sources): AEN rabbit pAb (1:400; Bioss), Caspase-3 rabbit pAb (1:200; Cell 
Signaling), CTIP2 rat mAb (1:200; Abcam), CUX1 rabbit pAb (1:50; Santa Cruz), EXOSC10 
rabbit pAb (1:500 for WB; Proteintech), EXOSC10 rabbit pAb (5μg for 100μl RIP-sample; 
Abcam), GFP chick pAb (1:400; Abcam), HUCD mouse mAb (1:20; Thermo Fisher Scientific), 
NEUN mouse mAb (1:200, Chemicon), REELIN mouse mAb (1:100), SATB2 mouse mAb 
(1:200; Abcam), SOX2 mouse mAb (1:100; Santa Cruz), SOX2 rat mAb (1:100; eBioscience), 
SOX5 rabbit pAb (1:100; Santa Cruz), TBR1 rabbit pAb (1:300; Abcam), TBR2 rabbit pAb 
(1:300; Chemicon), TBR2 rat mAb (1:200; eBioscience), TUJ mouse mAb (1:500; Chemicon), 
PAX6 mouse mAb (1:100; Developmental Studies Hybridoma Bank). Secondary antibodies 
used were Alexa 488-, Alexa 568-, Alexa 594- and Alexa 647-conjugated IgG (various species, 
1:400; Molecular Probes). 
 
3.12.2 Relative quantification of cortical size 
Relative quantification of cortical size was performed as described previously (Narayanan et 
al., 2018; Tuoc et al., 2013). Briefly, dorsal views of forebrains of mutant and control mice 
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were photographed under a dissection microscope. Cortical anterior-posterior axis (AP), 
cortical surface and midline lengths from the digitized images were measured with Fiji software 
to make comparison between mutants and controls. 
 
3.12.3 Immunohistochemistry (IHC) 
IHC was performed as described previously (Tuoc et al., 2009). Briefly, embryonic and 
postnatal brains were fixed in 4% paraformaldehyde, incubated in 25% sucrose in PBS-DEPC 
at 4°C overnight, embedded in Tissue-Tek O.C.T Compound (Sakura Finetek) on dry ice and 
cut in 8-16 μm coronal sections. After blocking with 5% goat or donkey normal serum, sections 
were incubated overnight with primary antibody at 4°C and the signal was detected with a 
fluorescent secondary antibody (Alexa Fluor; 1:400; Invitrogen). Sections were later 
counterstained with Vectashield mounting medium containing 4’-6’-diamidino-2-phenylindole 
(DAPI) (Vector Laboratories) to label nuclei. 
 
3.12.4 Quantitative RT-PCR (qPCR) and Western blot analyses 
qRT-PCR and Western blot analyses were performed as described previously (Tuoc and 















3.12.5 Cell counts and quantitative analysis of IHC signal intensity 
IHC quantification was performed using anatomically matched coronal sections. Nucleus 
marker-positive cells were counted using the Cell Counter plugin of Fiji (Schindelin et al., 
2012). In most cases, cell counts of six matched sections were averaged (control/cKO). The 
number of lineage marker cells was quantified using the total marker-positive cells in a defined 
region (radial unit) alone, or by normalizing to the total number of DAPI+ (nucleus-stained) 
cells using the following equation: Normalized number = marker-positive cell number/DAPI+ 
cell number. For quantitative analyses of IHC signal intensity of cytoplasm-staining markers, 
fluorescent images of selected areas of the cortex were used. Color images were converted to 
gray scale and the fluorescent signal intensity values were measured using the Analyze/Measure 
function of Fiji software. The signal intensity from the background next to the tissue was 
subtracted from the measured intensity for normalization. The normalized intensities of cKO 
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sections are displayed relative to normalized values from control experiments as a percentage. 
Statistical comparisons of histological data were performed using Student’s t-test. All bar 
graphs are plotted as means ± SEM. All statistical tests are two-tailed, and P-values are 
considered to be significant for p < 0.05 (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.005; NS, not 
significant). 
 
3.13 Additional supplementary information 
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Chapter 4: General Discussion 
In these studies, we investigated different mechanisms involved in cortical formation. First, we 
performed molecular profiling for IPCs and found several groups of genes specifically enriched 
in this highly relevant cell type. We further investigated the role of one of them, ESCO2, which 
is essential for sister chromatid cohesion during cell division. 
Second, we examined the function of the RNA exonuclease EXOSC10 in cortical 
development. We show its role in regulating apoptosis and indicate further functions, which 
will be subject of future studies. 
 
4.1 ESCO2 and other IPC-related factors in cortical (mal)formation 
Identification of cell type-specific genes by transcriptome analysis of molecularly sorted cells 
can improve the understanding of the molecular landscape of distinct cell lineages. Here, we 
demonstrate the molecular profiling of the evolutionarily and clinically significant IPCs in the 
embryonic mouse cortex. We found a strong correlation of the identified IPC genes and known 
human developmental disorders, corresponding to the crucial functions of IPCs in cortical 
development. 
A large proportion of cortical neurons originate from IPCs (Haubensak et al., 2004; 
Kowalczyk et al., 2009; Miyata et al., 2004; Noctor et al., 2004). These IPC-derived neurons 
form the upper cortical layers with their axons establishing the interhemispheric commissural 
system (i.e., the corpus callosum) (Fame et al., 2011). Evolutionary changes in the neurogenic 
output of IPCs have been linked to cortical expansion, especially seen in humans (Martinez-
Cerdeno et al., 2006). Thus, disruption in the production, differentiation and maintenance of 
IPCs can result in various cortical malformations and diverse neurological perturbations.  
Our GO analysis linked IPC-associated genes to neurodevelopmental defects, e.g. 
cortical size-related disorders (microcephaly, macrocephaly, and abnormal cortical gyration), 
corpus callosum defects (dysplastic, agenesis, aplasia, hypoplasia of corpus callosum, and 
abnormality of the cerebral white matter), and neurological deficits (intellectual disability, 
psychomotor developmental delay, schizophrenia, autism, and epilepsy).  
Overall, our molecular profiling data offer a resource for future investigations to 
increase our knowledge about the contribution of IPC-associated genetic factors in cortical 
formation and their role in neurological disorders. 
We next investigated the role of ESCO2, one of the IPC-related genes we identified by 
transcriptome analysis, in cortical development.  
Previous studies in yeast, primary mouse embryonic fibroblasts and human cells 
revealed that ESCO2 is essential for sister chromatid cohesion (Hou and Zou, 2005; Terret et 
al., 2009; Vega et al., 2005; Whelan et al., 2012a; Whelan et al., 2012b). ESCO2 mediates 
appropriate cohesion of sister chromatids by the acetylation of cohesin. Dysfunction of ESCO2 
leads to loss of cohesion, resulting in defective cohesin localization on chromosomes and finally 
causing apoptosis (Hou and Zou, 2005; Terret et al., 2009; Vega et al., 2005). Enriched ESCO1 
expression was found in RGCs in the ventricular zone and enriched ESCO2 expression in IPCs 
in the subventricular zone of the developing mouse cortex. Hence, the cohesin 
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acetyltransferases ESCO1 and ESCO2 seem to be cell viability determinants by ensuring 
correct tethering of sister chromatids in RGCs and IPCs, respectively. Indeed, our studies show 
that ESCO2 is substantial for IPC maintenance. 
Studying a mouse model for the novel IPC gene ESCO2, we found that IPC survival 
and maintenance in the developing cortex depend on ESCO2. ESCO2 is crucial for the correct 
segregation of chromatids and therefore the distribution of genetic material into the progenies 
of dividing IPCs. Its loss may have caused the massive apoptosis of ESCO2-deficient IPCs and 
the resultant cortical dysgenesis. 
Interestingly, ESCO2 mutations in human have been linked to the malformation 
syndromes RBS and JHS, which both include microcephaly and cognitive deficits (Kantaputra 
et al., 2020a; Kantaputra et al., 2020b; Van Den Berg and Francke, 1993; Vega et al., 2010). 
Karyograms from affected individuals show a characteristic heterochromatin puffing in the 
metaphase chromosomes resulting from impaired cohesion (Freeman et al., 1974; German, 
1979; Van Den Berg and Francke, 1993).  
Our study indicates that IPCs are particularly affected by the impaired cohesion. 
Previous studies reported that IPCs are transient amplifying progenitors in the developing 
cortex, undergoing multiple rounds of mitotic divisions (Hevner, 2019; Pontious et al., 2008). 
We found a high expression of numerous genes involved in cell cycle and chromatid 
segregation corresponding to the highly active cell division of IPCs. Thus, IPCs are especially 
vulnerable to loss of ESCO2 and the resulting impairment of cohesion, ultimately leading to 
apoptosis. The apoptosis of IPCs upon ESCO2 knockout and the subsequent failure in cortical 
formation seen in mice could also contribute to the microcephaly in humans with ESCO2 
mutations.  
 
4.2 The exosome complex in cortical (mal)formation 
We showed for the first time the significance of the RNA exonuclease EXOSC10 in the 
development of the cortex. Loss of EXOSC10 at a very early embryonic stage (from E8.5), lead 
to loss of the whole forebrain in mice. If EXOSC10 is lost a few days later (from E10.5), the 
forebrain develops, however, the cortical size is reduced severely.  
We found that EXOSC10 regulates the expression of apoptosis regulating factors by 
degrading their mRNAs. The binding of EXOSC10 to the transcripts of the P53 signaling 
mediators AEN and BBC3 and probably others leads to their rapid turnover. Loss of EXOSC10 
creates an imbalance in production and decay of apoptosis-related transcripts leading to an 
accumulation of these, ultimately causing healthy cells in the developing cortex to undergo 
apoptosis. The resulting cell death contributes to the reduction of cortical size. As microcephaly 
is also observed in humans with an EXOSC10 mutation, one could assume that this function in 
the regulation of apoptosis is preserved from mouse to man. 
Similar observations were done in a study of EXOSC8 or EXOSC9 mutant zebrafish 
(Muller et al., 2020). Zebrafish larvae with a homozygous frameshift mutation in EXOSC8 or 
EXOSC9 displayed smaller heads and eyes and cerebellar atrophy due to an increase of 
apoptotic cells (Muller et al., 2020). Consistently, higher P53 levels were found in affected 
zebrafish. Increased P53 was also observed in cultured human cells treated with siRNA for 
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EXOSC8 or EXOSC9 mRNA as well as in muscle samples from patients with EXOSC9 
mutations (Muller et al., 2020).  
Thus, the role of the exosome complex in cell survival by regulating P53 signaling might 
be a general mechanism contributing to the neurodegeneration observed in human patients with 
mutations in exosome complex subunits. Nevertheless, the variability of human disorders 
caused by mutations of different subunits indicates that different pathways may be involved. 
The different subunits may have diverse cell type- and tissue-specific functions, which still 
need to be uncovered. 
 
4.3 Future directions: EXOSC10 in SHH and WNT/β-catenin signaling 
We are preparing a manuscript about EXOSC10 mutations causing microcephaly in patients 
(Fig. 1.1). The smaller brain corresponds to our finding that loss of EXOSC10 increases P53 
levels, ultimately resulting in apoptosis. As all known patients are heterozygous for a mutation 
of EXOSC10, we decided to investigate the heterozygous condition in mice as well. Our first 
data show that the heterozygous brain is less severely affected than the homozygous conditional 
knockout, however, an increase of apoptotic cells and a reduced size of the cortex were detected 
corresponding to the microcephaly observed in humans with EXOSC10 mutation (Fig. 4.1A, 
B). 
As no patients with a homozygous mutation of EXOSC10 are known, the homozygous 
condition is likely to be lethal, similar as in the EXOSC10cKO_FoxG1-Cre mice. In the FoxG1-
Cre mice, which loose EXOSC10 early starting from E8.5 (Hebert and McConnell, 2000), the 
forebrain fails to develop (Figure S3.2). 
Nevertheless, regulating cell survival might not be the only way in which the exosome 
complex contributes to proper neurodevelopment. In EXOSC10cKO_Emx1-Cre mouse 
embryos, a decrease of neural stem cells and an increase of intermediate progenitor cells and 
neuronal cells was observed (Fig. 4.1C, D). These observations correspond to previous studies 
reporting that the exosome complex regulates the balance of differentiation and progenitor 
maintenance in other cell types, such as embryonic stem cells, epidermal cells and erythroid 
precursor cells (Belair et al., 2019; McIver et al., 2014; McIver et al., 2016; Mistry et al., 2012). 
RNA sequencing of E12.5 EXOSC10 cKO mouse cortices revealed an upregulation of 
neuron differentiation transcripts combined with downregulation of transcripts of genes known 
to be involved in NSC fate and cell cycle (Fig. 4.1E, F). Interestingly, several transcripts of 
SHH signaling (SHH, PTCH1) and WNT signaling pathways (WNT3, WNT9b) were 
upregulated. 
Binding of SHH to Patched (PTCH) receptors (PTCH1 and PTCH2) relieves the PTCH-
mediated inhibition of the Smoothened (SMO) receptor (reviewed by Choudhry et al., 2014; 
Rimkus et al., 2016). The resulting signal transduction from SMO through the cytoplasmic 
SUFU-GLI complex leads to the activation of GLI1-3. GLI1-3 are transcription factors 
modulating the expression of target genes with GLI1 and GLI2 acting as transcriptional 
activators and GLI3 as repressor.  
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Binding of WNT activators (e.g. WNT3) to the Frizzled/LRP receptor complex leads to 
the release of β-catenin from the cytoplasmic β-catenin destruction complex (reviewed by 
Logan and Nusse, 2004; MacDonald et al., 2009). β-catenin, which is degraded in the absence 
of WNT, then accumulates in the nucleus where it acts as a transcription factor. 
Crosstalk between the SHH and WNT pathways forms regulatory loops (Ding and 
Wang, 2017; Mullor et al., 2001; Nakamura et al., 2013; Noubissi et al., 2009; Song et al., 
2015). For example, GLI2/3 was found to regulate WNT proteins (Mullor et al., 2001). 
Additionally, SHH was shown to increase β-catenin levels through the transcription factor N-
myc in cerebellar granule neuron progenitors (Mani et al., 2020). Vice versa, WNT/β-catenin 
signaling was found to increase GLI1 expression by inducing expression of the RNA-binding 
protein CRD-BP, which binds and stabilizes GLI1 transcripts (Noubissi et al., 2009). 
In patterning of the CNS, SHH and WNT signaling are known to have opposing effects. 
Whereas SHH induces ventral identity, WNT signaling is responsible for the dorsal fate (Ulloa 
and Marti, 2010). This results in the production of pyramidal neurons in the dorsal part and 
interneurons in the ventral part of the telencephalon, creating the two main populations of 
cortical neurons (Gulacsi and Anderson, 2008; Li et al., 2009). 
In the context of balancing proliferation and differentiation, both, SHH and WNT 
signaling, have been shown to be essential for progenitor proliferation as well neuronal 
differentiation. Several studies showed that SHH signaling promotes proliferation in the 
developing brain. In SHH null mice, not only dorsoventral patterning but also general brain 
proliferation is affected leading to a severe reduction in size (Chiang et al., 1996; Rallu et al., 
2002). Ectopic SHH expression in the developing spinal cord revealed an essential function in 
the expansion of granule cell precursors (Rowitch et al., 1999). Also in the postnatal 
telencephalon, SHH was shown to be required to maintain progenitor cells (Machold et al., 
2003). In addition to its role in NSCs, SHH signaling was also shown to be important for 
neuronal differentiation. In the dorsal telencephalon, upregulation of SHH signaling increased 
the transition of RGCs to IPCs (Shikata et al., 2011). Studies indicated that SHH regulates 
proliferation and differentiation of cortical neurons through coordination of cell cycle kinetics 
(Komada et al., 2008; Ruiz i Altaba et al., 2002). In conclusion, the various roles of SHH 
signaling during development of the telencephalon depend on the region, concentration and 
timing of expression (Komada, 2012). 
Several studies revealed that canonical WNT signaling promotes proliferation. 
Overexpression of β-catenin increased cortical NSC proliferation (Chenn and Walsh, 2002). 
Also the expression of neurogenic genes was delayed by ectopic expression of β-catenin and 
accelerated by β-catenin ablation (Machon et al., 2007). Nevertheless, the canonical WNT 
pathway also regulates the differentiation of IPC into neurons. Overexpression of the WNT 
activator WNT3a leads to upregulation the WNT signaling and induces premature 
differentiation of IPC into neurons (Munji et al., 2011). The authors suggest that the effects of 
WNT signaling depend on the context defined by the progenitor state and/or the developmental 
time (Munji et al., 2011). This idea is further supported by a study indicating that canonical 
WNT signaling affects the fate-switch of progenitors and controls the stage-specific production 
of progenitors and neuronal subtypes (Draganova et al., 2015). 
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Our preliminary data suggest that dysregulation of SHH and WNT signaling is likely to 
contribute to the phenotype of EXOSC10cKO mice. The role of EXOSC10 in the complex 
interplay of canonical SHH/WNT signaling in cortical patterning and in the 
proliferation/differentiation balance will be subject of our future investigations. 
Besides, in human diseases, mutations of different subunits cause distinct phenotypes 
with different tissues and cell types affected. Similarly, the subunits display different expression 
patterns in the developing cortex (Fig S3.1). Hence, one could assume tissue- and cell type-
specific functions of the subunits. Additionally, yet unknown interactions with other proteins 
could confer the tissue specificity. Therefore, further studies on the role of the exosome 
complex and its individual subunits in different tissues are necessary. For example, it would be 
interesting to use different mouse models for the individual complex subunits of the exosome 
complex to investigate their probably different roles in cortical development. Further molecular 
approaches, like co-immunoprecipitation, could reveal specific interactions of the individual 
subunits with other regulatory factors. 
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Figure 4.1 Loss of EXOSC10 leads to reduction of cortical size and promotes neuronal differentiation in 
homozygous and heterozygous condition. 
(A) DAPI staining of P6 control (wild-type), EXOSC10Het (EXOSC10COIN/+ Emx1-Cre) and EXOSC10cKO 
(EXOSC10COIN/COIN Emx1-Cre). Rostral and caudal sections are shown. (B) Bar graph presenting quantification of 
the cortical diameter in P6 EXOSC10Het and cKO mice relative to control displaying significant differences. (C) 
Micrographs at 10x and 40x magnifications of E12.5 control, EXOSC10Het and cKO cortex immunostained for 
PAX6 and HUCD. Lower images are higher magnifications indicated by the white frame. (D) Bar graph showing 
quantification of cells positive for PAX6 AND HUCD among all PAX6+ cells in the E12.5 control, EXOSC10Het 
and cKO in the cortical area marked with a white frame in C. (E) Volcano plot showing changes in gene expression 
detected in RNA-seq (E12.5 EXOSC10cKO cortex versus control) (for method see 3.5.4). (F) Bar graph showing 
upregulated (enriched) neuron differentiation genes and downregulated NSC and cell cycle genes in 
EXOSC10cKO cortex compared to control at E12.5 (revealed by RNA-seq). Statistical analyses were carried out 
using Student’s t-test. Graphs are plotted as mean (± SEM). An unpaired t-test was carried out on the average from 
at least two biological replicates for each condition. *P<0.05, **P<0.01, ***P<0.005. Scale bars: 1 mm (A), 100 
µm (C). 
 
4.4 RNA editing gives hope for future therapies 
The increasing number of neurodevelopmental diseases linked to mutations in genes encoding 
subunits of the exosome complex emphasizes the importance of stepping up research efforts 
into understanding how the exosome complex regulates neurodevelopment. So far, for exosome 
complex related diseases (summarized in Table 1, page 12), no cure is available and only 
symptoms can be treated. In future, the novel technique of RNA editing might be the treatment 
of choice and improve the lives of affected individuals. 
In the last few years, genome editing using the CRISPR system became a promising 
research area to develop new therapies for genetic diseases (Wu et al., 2020). However, possible 
“off-target” effects could introduce unwanted changes, which would be permanent in the 
genome (Fu et al., 2013; Zhang et al., 2015). RNA editing might be a reasonable alternative 
enabling to change the genetic output without the need of genome editing (Christofi and 
Zaravinos, 2019; Reardon, 2020). As mRNAs are stable only for a limited time, possible 
introduced errors would be removed quickly, making this therapy reversible and less dangerous 
than genome editing (Merkle et al., 2019). Besides, with RNA editing it is possible to introduce 
temporary changes making the method also interesting for the treatment of various other 
diseases (Katrekar et al., 2019; Merkle et al., 2019; Reardon, 2020). For example, turning off 
key signaling factors temporarily could be a powerful tool in the treatment of tumours (Merkle 
et al., 2019; Reardon, 2020).  
The most common type of RNA editing, is the A-to-I conversion, which means the 
change of adenosine to inosine (Bazak et al., 2014). During translation, ribosomes read inosine 
as the familiar guanosine (Basilio et al., 1962). The enzymes, which bind to RNA and perform 
the A-to-I conversion, are called ADARs (adenosine deaminases acting on RNA) (Bass, 2002; 
Nishikura, 2016). In mammals, three ADAR genes (ADAR1-3) were found to generate four 
isoforms DAR1p150, ADAR1p110, ADAR2 and ADAR3 (Melcher et al., 1996a; Melcher et 
al., 1996b). Another group of enzymes belong to the AID/APOBEC (activation-induced 
cytidine deaminase/apolipoprotein B editing complex) family and perform a C-to-U conversion 
meaning they change cytidine to uridine in mRNA (Fossat et al., 2014; Smith et al., 2012).  
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Different approaches are used to direct ADARs to target mRNA. Sequence-specific guide RNA 
can either be attached to ADAR or contain an ADAR-recruitment domain (Fukuda et al., 2017; 
Katrekar et al., 2019; Merkle et al., 2019; Montiel-Gonzalez et al., 2013; Vogel et al., 2018). 
By attaching ADARs to guide RNA, which binds to a specific stretch of mRNA creating a 
double-strand, ADARs can be engineered to alter a specific mRNA (Montiel-Gonzalez et al., 
2013; Vogel et al., 2018). Using this, defective mRNA was successfully edited in Xenopus 
embryos as well as in cultured human embryonic kidney cells (Montiel-Gonzalez et al., 2013). 
In a mouse model for Duchenne muscular dystrophy caused by a mutation inducing a premature 
stop codon in the dystrophin gene, injection of a guide RNA containing ADAR-recruiting 
domains packed in an AAV vector into muscle tissue could restore dystrophin expression 
(Katrekar et al., 2019).  
Alternatively, an ADAR can also be fused to an RNA-targeting protein like CAS13 to 
direct the ADAR to certain transcripts specifically (Abudayyeh et al., 2019; Cox et al., 2017). 
Despite the promising findings, there are several limitations to this novel technique, 
which is just starting to evolve. One challenge is the efficiency of RNA editing, as ADARs are 
less efficient than CRISPR (Reardon, 2020). Additionally, they might have to compete with 
nonsense mediated decay of their target mRNA (Katrekar et al., 2019).  
Using ADARs or AID/APOBECs to edit RNA, it is possible to change a single 
nucleotide. By this, a pathogenic base substitution could be reversed. However, if the disease 
causing allele contains a nucleotide deletion or inversion, the resulting mRNA cannot be 
corrected by the known RNA editing tools. 
Besides, even the ability to exchange single nucleotides is restricted to changes from 
adenosine to guanine and from cytosine to uracil further limiting the disease variants, which 
could be treated. Current RNA editing possibilities could be expanded not only by finding more 
RNA editing enzymes in nature but also by altering existing enzymes. For example, by 
changing its sequence, ADAR2 was evolved to convert C to U (Abudayyeh et al., 2019). The 
engineered cytidine deaminase is still able to convert A to I as well (Abudayyeh et al., 2019). 
The function of the modified ADAR2 enzyme was tested successfully in cultured human cells 
(Abudayyeh et al., 2019).  
Another challenge is the transfer of the engineered guide mRNA into the cells. Chemical 
modifications could stabilize guide RNAs to prevent degradation or they could be transferred 
into cells via nanoparticles or viruses (Merkle et al., 2019; Reardon, 2020).  
ADARs occur naturally in human cells, however in most tissues they are produced only 
in small amounts raising the question if relying on the naturally occurring ADARs is sufficient 
or if it might be necessary to add ADARs (Merkle et al., 2019; Reardon, 2020). Also attracting 
natural occurring ADARs via ADAR-recruiting domains in guide mRNA to the target mRNA 
could lower their capability to fulfil their normal functions (Katrekar et al., 2019; Reardon, 
2020). This could lead to so far unknown health issues and it shows that more research is needed 
before the technique can be applied in humans. 
Once these challenges are overcome, the diseases caused by mutations in the exosome 
complex are obvious candidates for a treatment with RNA editing as the diseases are caused by 
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a base substitution in most of the individuals. Modifying the mRNA of the affected exosome 
complex subunit could reverse the effect of the genetic mutation at least partially. 
One challenge in the treatment of diseases caused by mutations of the exosome complex 
would be the starting point of treatment. Diagnosis usually occurs when symptoms are already 
present. At this time point, processes like apoptosis may already have caused damage, which 
cannot be reversed completely. However, as brain growth and development continues, starting 
a treatment in the first years of life would still have potential to reduce the severity of symptoms. 
Especially, with PCH1 and HSP being progressive neurodegenerative diseases, they are good 
candidates for intervention. 
 
4.5 EXOSC10 might be beneficial for a novel RNA editing tool 
In addition to the RNA editing tools mentioned before, others tools have been used to target 
defective m6A sites (reviewed by Sokpor et al., 2021). Therefore, the ability of CAS13 family 
proteins to target RNA is used (Burmistrz et al., 2020; Wang et al., 2019). Deactivated CAS13b 
(dCAS18b) is catalytically inactive, but its RNA-binding ability is preserved. A guide RNA 
(gRNA) is fused to dCAS13b to target a specific RNA sequence. The gRNA-dCAS13b is 
further coupled to a certain effector. This effector can be an m6A writer to add an m6A methyl 
group, an m6A eraser to demethylate m6A or m6A readers to enhance translation or induce 
RNA degradation (Sokpor et al., 2021). Recently, several transcripts have been successfully 
targeted by this tool (Li et al., 2020a; Mo et al., 2020; Rauch et al., 2018; Wilson et al., 2020; 
Zhao et al., 2020). 
For instance, malfunction of methyltransferases (METTL3 and/or METTL14) leads to 
missing m6A marks on gene transcripts (Agarwala et al., 2012; Geula et al., 2015; Liu et al., 
2014). Fusions of dCAS13 with a METTL3 methyltransferase domain or with a modified 
METTL3:METTL14 complex can compensate this malfunction by introducing m6A marks 
(Wilson et al., 2020). The site-specific addition of methylation marks was shown for several 
transcripts, including the ones from SOX2, FOXM1 and ZNF638 in human embryonic kidney 
cells (Wilson et al., 2020). 
When used as an effector fused to dCAS13b, the m6A reader YTHDF2 was reported to 
induce degradation of the targeted transcript (Rauch et al., 2018). However, the degradation is 
limited to transcripts known to be m6A modified. By using EXOSC10 as the effector, the 
possibilities of RNA editing could be further expanded. A gRNA-dCAS18b-EXOSC10 
complex could degrade various target mRNAs specifically and directly without the need of 
m6A marks. 
The resulting new tool for targeted RNA degradation could be applied for the treatment 
of various genetic diseases. Especially, gain-of-function mutations, which lead to increased 
abundance or activity of a certain protein, could be treated by this tool. Binding to a specific 
mRNA by dCAS18b followed by EXOSC10-mediated degradation could reduce the amount of 
mRNA resulting in decreased amount of protein. Notably, rather than knocking out a specific 
gene, the degradation of its transcript would be dose-dependent and reversible. 
For example, gain-of-function mutations in the RARB gene cause a complex 
neurological phenotype (Srour et al., 2016; Srour et al., 2013). Affected patients display eye 
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malformations (microphthalmia) and severe developmental delay with progressive motor 
impairment (Srour et al., 2016). RARB stands for retinoic acid receptor beta, one subtype of 
several existing retinoic acid (RA) receptors. Upon binding of RA, the RA receptor complex 
acts as a transcription factor by binding to specific DNA sequences, known as RA response 
elements (RAREs) (Collins, 2002; Glass and Rosenfeld, 2000). The pathogenic mutations of 
RARB identified in patients increase its transcriptional activation potential in response to RA 
ligands by two- to threefold (Srour et al., 2016; Srour et al., 2013). EXOSC10-mediated 
degradation of a certain proportion of RARB transcripts could counteract the increased activity 
of the RARB protein. An early intervention has potential to improve cognitive and motor 
development of affected patients. 
Similarly, diseases caused by gene duplications could potentially treated by RNA 
editing using EXOSC10. For example, duplications and triplications of the gene coding for α-
synuclein (SNCA) have been linked to familiar Parkinson’s disease (Nishioka et al., 2006; 
Singleton et al., 2003). Targeted degradation of SNCA transcripts by EXOSC10 could change 
the amount of SNCA protein back to physiological levels. 
So far, a gRNA-CAS18b-EXOSC10 complex has not been created and the functionality 
of such a complex would have to be tested in cells at first. Nevertheless, the use of EXOSC10 




Figure 4.2 Illustration of a proposed gRNA-dCAS18b-EXOSC10 complex. Deactivated Cas13b (dCas13b) is 
fused with a guide RNA (gRNA) to specifically target a certain mRNA. Coupling to EXOSC10 may lead to 
degradation of the targeted transcript. Created with BioRender.com. 
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Summary 
This work focuses on elucidating the molecular mechanisms that control the cortical 
development. Identification of genes and factors that direct the development of the cerebral 
cortex will both tell us about their disease-related importance and improve our understanding 
of the normal formation and malformation of the cortex. 
In the first part, we performed transcriptome analysis to determine the molecular profile 
of IPCs, which play a crucial role in cortical formation as they generate the majority of cortical 
neurons. Accordingly, we sorted TBR2+ IPCs from the embryonic mouse cortex and analysed 
gene expression profiles of TBR2+ IPCs versus TBR2- cell populations. We identified different 
levels of key genetic factors regulating chromatid segregation, cell-cycle progression, 
transcription, and cell signaling. Remarkably, in humans, mutations of several identified IPC 
genes are linked to various cortical malformations, like microcephaly and macrocephaly, corpus 
callosum defects, and neurological deficits. For example, mutations in the cohesin 
acetyltransferase ESCO2, one of the newly identified IPC genes, cause severe malformations 
including microcephaly. We showed that deficiency of ESCO2 in the developing mouse cortex 
leads to severe loss of IPCs, resulting in cortical malformation. We thereby demonstrate the 
identification of a central genetic factor of IPC genesis. Our molecular profiling data reveal 
novel molecular characteristics of IPCs and offer a resource for future investigations. 
Recent sequencing analyses of cortical malformations revealed a multifarious genetic 
landscape. In our pilot work, we identified novel microcephaly-related mutations in a gene 
encoding EXOSC10, a core subunit of the RNA-decay exosome complex. In the second part of 
this work, we characterized the cortical phenotypes of EXOSC10cKO mutants. We showed that 
EXOSC10 is essential for forebrain formation. EXOSC10 deficiency in the developing mouse 
cortex causes massive apoptosis in cortical cells resulting in cortical malformation. We found 
that EXOSC10 binds and degrades mRNA coding for P53 signaling-mediators, like AEN and 
BBC3. Additionally, our studies indicate that EXOSC10 plays a role in regulating the 
differentiation of cortical progenitors. It might do so via degrading transcripts of the 
SHH/WNT-β catenin signaling pathways. Further investigations are needed to illuminate this 
additional role of EXOSC10. In conclusion, our study reveals an essential role of EXOSC10 in 
suppressing the P53, SHH/WNT-β catenin pathways, which are indispensable for cell survival, 
neurogenesis and normal cortical formation. Our findings of the mouse model correspond to 
observations of humans with microcephaly linked to EXOSC10 mutations. 
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